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ABSTRACT
The expression of retina-specific genes is essential for retinal development during
embryogenesis and for maintaining the differentiation of photoreceptor and retinal
pigment epithelial (RPE) cells. The regulation of these genes is controlled by retinal
transcription factors that bind to specific DNA sequences in the regulatory regions of
target genes. Amino acid mutations in some of these factors such as orthodenticle
homeobox 2 (OTX2) and microphthalmia-associated transcription factor (MITF) are
connected with severe ocular malformations e.g. microphthalmia or anophthalmia.
Mutations in DNA-binding sites may also cause aberrant target gene expression and
associate with retinal disorders but their significance is currently unclear.
      In the present studies, several human retina-specific gene promoters (rhodopsin, rod
arrestin, rod transducin-, rod PDE, IRBP, cone blue opsin and tyrosinase) were cloned and
their functionality was studied in cultured photoreceptor and RPE cell models with
reporter gene assays. Moreover, the role of transcription factors MITF and OTX2 in
regulation of the human tyrosinase gene was studied in detail. Importantly, a new type of
gene delivery method, reverse transfection, was developed for post-mitotic retinal cells to
facilitate detailed analysis of weak gene promoters.
     In summary, only the gene promoter of interphotoreceptor retinoid binding protein
(IRBP) displayed clear activity and was specifically active in the photoreceptor cell model.
The presented data indicates that the cell model had only partially differentiated to
photoreceptors. Regulation of the human tyrosinase, a rate-limiting enzyme in
melanogenesis, was studied in cell models resembling human RPE and in melanocytes. In
RPE cells, OTX2 factor was an essential regulator of the human tyrosinase gene.  Trans-
activation of tyrosinase by OTX2 was mediated by three novel binding elements as well as
a novel OTX2-MITF protein-protein interaction that did not require any OTX2 binding
sites. A genetic polymorphism in one of the OTX2 binding sites dramatically decreased the
activity of tyrosinase expression in the RPE cells. This suggests a functional role of OTX2
in RPE depigmentation. Due to the association of depigmentation with age-related
macular degeneration in epidemiological studies, the present findings provide a basis for
further investigation of genetic variants associated with abnormal RPE pigmentation.
National Library of Medical Classification: QU 475, WW 101, WW 270
Medical Subject Headings: Eye; Retina; Promoter Regions, Genetic; Eye Proteins; Cloning, Molecular;
Photoreceptor Cells; Retinal Pigment Epithelium; Transcription Factors; Microphthalmia-Associated
Transcription Factor; Otx Transcription Factors; Transfection; Retinol-Binding Proteins; Monophenol
Monooxygenase; Melanins; Retinal Pigments; Polymorphism, Genetic
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TIIVISTELMÄ
Silmän verkkokalvolla eli retinalla ilmentyvillä geeneillä on merkittävä rooli
fotoreseptorien ja retinan pigmenttiepiteelin (RPE) solujen muovautumisessa
alkionkehityksen aikana sekä solujen erilaistumisen ylläpitäjänä aikuisiällä. Näiden
geenien säätelystä vastaavat retinassa ilmentyvät transkriptiotekijät. Mutaatiot
orthodenticle homeobox 2 (OTX2)  ja microphthalmia transkriptiotekijöissä (MITF) voivat
johtaa vakaviin silmän kehityksen häiriöihin. Toisaalta näiden transkriptiotekijöiden
sitoutumisalueilla kohdegeenien promoottoreissa esiintyvistä variaatioista ja niiden
yhteydestä retinan sairauksiin on vielä hyvin vähän tietoa.
    Tässä väitöskirjatyössä kloonattiin useita retinassa aktiivisia geenipromoottoreita
(rodopsiini, arrestiini, transdusiini-, PDE, IRBP, siniopsiini and tyrosinaasi). Promoottorit
liitettiin lusiferaasia ilmentävään reportterigeeniin ja niiden säätelyä tutkittiin retinan
fotoreseptoreja ja pigmenttiepiteeliä muistuttavissa solumalleissa. Tämän lisäksi OTX2- ja
MITF-transkriptiotekijöiden roolia tyrosinaasin ilmentymisessä tutkittiin
yksityiskohtaisemmin. Tässä tutkimuksessa kehitettiin uudenlainen
geeninsiirtomenetelmä, käänteistransfektio, jonka avulla voitiin tutkia heikosti aktiivisia
geenipromoottoreita jakautumattomissa retinan soluissa.
    Yhteenvetona voidaan todeta, että käytetyn fotoreseptorisolumallin erilaistumiskyky oli
rajallinen. Tutkituista fotoreseptoreissa aktiivisista geeneistä vain retinoidien
kuljetusproteiinia (IRBP) säätelevä geenipromoottori toimi spesifisesti solumallissa.
Pigmentaatiota säätelevän tyrosinaasin geenipromoottori oli aktiivinen silmän RPE-
soluissa ja OTX2:lla oli merkittävä rooli sen aktivaatiossa. Ihmisen tyrosinaasi-
promoottorista löydettiin kolme toiminnallista OTX2:n sitoutumispaikkaa, joista yksi oli
polymorfinen. OTX2 kykeni aktivoimaan tyrosinaasipromoottorin myös uudenlaisen
MITF-välitteisen proteiinivuorovaikutuksen kautta. Polymorfia OTX2:n
sitoutumispaikassa johti merkittävään tyrosinaasipromoottorin aktiivisuuden laskuun
RPE-soluissa.  Kyseisen polymorfian merkitys retinan pigmentaatioon in vivo on epäselvä,
mutta tämän löydöksen kiinnostavuutta lisäävät laajat epidemiologiset tutkimukset, jotka
osoittavat, että retinan vähentynyttä pigmentaatiota esiintyy yleisesti verkkokalvon
ikärappeumaa sairastavilla potilailla.
Luokitus: QU 475, WW 101, WW 270
Yleinen Suomalainen asiasanasto: geenit; geenitutkimus; geeniekspressio; silmät; verkkokalvo;
proteiinit; solut; valoreseptorit; verkkokalvon pigmenttiepiteeli; kloonaus; transkriptio;
promoottorialueet; melaniinit; verkkokalvon pigmentit; polymorfismi
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1  Introduction
Throughout the animal kingdom, the sense of vision is almost essential for survival. Visual
acuity and the generated sharp image actually involve the fine-tuned co-operation of
numerous processes such as adaptive lenses, light detection, colour vision, dark
adaptation as well as stereo vision and the capability to distinguish and recognize objects.
All  this  results  from  the  seamless  cooperation  between  the  eye  and  the  brain  which  is
supported by the memories of previously recorded visual responses. If one of these
elements malfunctions, then visual acuity is threatened. In human, numerous mutations in
the coding regions of the retinal genes have been shown to associate with degenerative
retinal diseases such as retinitis pigmentosa. In contrast, there is only limited information
on disease-associated polymorphisms in the gene regulatory regions which are
additionally believed to be causative candidates of these diseases but more challenging to
investigate. For instance, association of polymorphisms in transcriptional regulation in
complex retinal diseases such as age-related macular degeneration (AMD) is plausible but
still completely unclear. AMD interferes with the daily routines of over 30 million people
worldwide and is responsible for about 50% of all cases of blindness in Western countries
(WHO Vision 2020 Action plan 2006-2011, Gehrs et al. 2006). This number of AMD
patients  is  predicted  to  double  within  the  next  10  years  due  to  the  rapid  increase  in  the
aging population. AMD shows a significant heritability of 71% but its genetic components
are still a mystery. Evidence from large epidemiological studies and pathological findings
indicate that inflammation and depigmentation of the retinal pigment epithelium (RPE)
are commonly observed in AMD patients (Thompson et al. 2007, Scholl et al. 2007, Hu et
al. 2008). Most of the current information regarding genetic factors associated with the
synthesis of melanin pigment has been gathered from skin melanocytes whereas the
regulation of melanogenesis in the RPE is poorly understood.
The  present  study  focuses  on  the  regulation  of  the  retinal  gene  promoters  which  are
specifically active in the retinal pigment epithelium (RPE) and photoreceptor cells. First,
the role of melanin in the biology of the eye, ocular development, and retinal disorders
will be reviewed. Since the role of the highly melanized RPE is crucial for the welfare of
the entire retina and vision, regulation of tyrosinase, the rate-limiting enzyme in melanin
biosynthesis, was studied in detail. The role of orthodenticle homeobox 2 (OTX2) and
microphthalmia-associated transcription (MITF) factors in regulation of tyrosinase gene was
studied in several cell models and in vitro. In addition to tyrosinase, several photoreceptor
cell-specific gene promoters were cloned and studied in photoreceptor cell models.
Importantly, a novel gene delivery method, reverse transfection, was developed to enable
detailed analysis of promoters in “hard-to-transfect” retinal cells.
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2.1  OVERVIEW OF THE RETINA AND ITS DEGENERATIVE DISEASES
Retinal tissue is made up of several layers of individual cell types with specialized
functions. Due to the close interaction of the retinal cell layers, malfunction of a single cell
population can destabilize the whole visual process. A large proportion of common ocular
diseases with impaired vision or blindness result from retinal dysfunction.
2.1.1 Anatomy of the retina
Eye development during the embryogenesis is a complex cellular network where the
retinal pigment epithelium (RPE) and photoreceptor cells develop in concert. A group of
transcription factors (Swaroop et al. 2010) as well as factors secreted by the RPE are
responsible for differentiation and fate of photoreceptor cells (Jeffery 1998, Martinez-
Morales et al.  2004). The development of the retina starts from the formation of the optic
vesicle which occurs three weeks after fertilization (Forrester et al. 1996). Photoreceptors
within the neural retina and the cuboidal RPE cells achieve their typical morphology about
five months after fertilization but multiplication of specific cell populations ceases just
before birth. The final characteristics of the retina (Fig. 1.) at  the  molecular  level  are
achieved two years after birth when polymerization of the RPE melanin pigment is
terminated (Hu, Simon and Sarna 2008.). Photoreceptors within the neural retina are
responsible for the absorption of photons and phototransduction. A single cell layer of the
RPE lies between the photoreceptor cells and the heavily vascularized choroid (Strauss
2005). The RPE has multiple functions from maintenance of photoreceptors to absorption
of scattering light, while the choroid nourishes the other retinal cell layers by providing a
sufficient flow of blood through its vascular network.
2.1.2 Photoreceptors and retinal pigment epithelium: role in visual system.
Photoreceptors and the RPE undergo an active interplay and are separated only by the
thin subretinal space filled with the interphotoreceptor matrix (Marmorstein et al. 1998).
Every RPE cell is facing around 20 to 40 photoreceptor cells (Futter 2006). The average RPE
density is about 4000 cells per mm2 at the fovea, decreasing towards the periphery (Panda-
Jonas et al. 1996). The tips of the photoreceptor outer segments (POS) point towards the
apical RPE microvilli (Fig. 2.). Phagocytosis of shed POS into the surrounding RPE
microvilli enables POS renewal (Kevany and Palczewski 2010). Even though the
photoreceptors and RPE are non-dividing, post-mitotic cells, they are metabolically
extremely active, having one of the highest metabolic turnover rates in the human body
(Forrester et al. 1996).
3Figure 1. Anatomy of the eye and retina. The neural retina contains different cell types
responsible for phototransduction: cone (C) and rod (R) photoreceptors, bipolar cells (bc),
ganglion  cells  (gc),  horizontal  cells  (hc),  amacrine  cells  (ac)  and  Müller  glial  cells  (Mc).  The
heavily pigmented single cell layer of the retinal pigment epithelium (RPE) resides between the
neural retina and the choroid. The highly vascularized choroid (ch) is separated from the RPE
by Bruch´s membrane (Bm). The choroid is nourished by the choriocapillary (cc) network and
is heavily pigmented by the choroidal melanocytes (m). Adapted from Graw 2003, Swaroop et
al. 2010, Sung and Chuang 2010.
4Figure 2. In the sub-retinal space of the retina, the outer segments of photoreceptors project
towards the apical microvilli of the RPE. The RPE is responsible for the renewal and function of
photoreceptors by assuring the recycling of retinoids, nutrient transport, retinal-blood-barrier
and  enabling  the  daily  phagocytosis  of  photoreceptor  outer  segments  (POS)  shed  from  the
photoreceptors.  Heavily  pigmented  melanosomes  at  the  apical  side  of  the  RPE  provide
photoprotection  against  the  sunlight  and  are  also  a  powerful  scavenger  of  free  radicals.
Adapted from Marmostein et al. 1998, Strauss 2005, Sung and Chuang 2010.
Photoreceptors and visual system – The visual process is initiated from the
photoreceptors on the outer retina. Photoreceptors convert incoming light energy to
electrical signals which are processed and amplified in neural retinal cells (photoreceptors
 bipolar cells  ganglion cells)  and finally  transmitted throughout  the  optic  nerves  to
the visual cortex of the brain (Baylor D. 1996, Forrester et al. 1996). Rod photoreceptors
located on the  periphery of  retina  detect  the  low levels  of  light  required for  night  vision
whereas  cones  located on the  macula  are  responsible  for  central  color  vision in  daylight.
The  light-sensing  opsins  are  transmembrane  proteins  situated  on  POS  internal  disk
membranes (Fig. 3) (Sung and Chuang 2010). Disks of the rod outer segments contain
visual pigment, rhodopsin, that consists of 11-cis-retinal,  which is  isomerized to  all-trans
retinal after light absorption. Cones express one of the three visual pigments called blue,
red and green opsins, each sensitive to a specific waveband of light (Swaroop et al. 2010).
In the process of phototransduction (Fig. 3), the energy of the light absorbed by opsin is
converted into an electrical signal through the involvement of several photoreceptor-
specific proteins on the photoreceptor disc membrane such as transducins and cGMP-
phosphodiesterases (PDEs) which hydrolyze cyclic GMP (cGMP) to GMP (Cote RH 2004).
In this cascade, a rapid decline in cellular cGMP levels closes cGMP-gated cation channels
on  the  plasma  membrane.  This  induces  a  temporary  decline  of  calcium  ion  (Ca2+) levels
and hyperpolarization of the photoreceptor cell (Molday RS 1998, Sung and Chuang 2010).
In  the  dark (Fig. 3), phototransduction is quenched by phosphorylation of rhodopsin, a
process mediated by the recoverin-rhodopsin kinase complex and the binding of arrestin
(Ridge et al. 2003).
5Figure 3. Schematic diagram of phototransduction within the photoreceptors. In the
phototransduction cascade, absorption of a light photon is converted into an electrical signal by
hyperpolarization of the photoreceptors.  The hyperpolarization signal is transmitted to other
cells of the neural retina and finally to the visual cortex of the brain through neurotransmitter
pathways. In the disc membrane, absorption of light changes the conformation of the
chromophore, 11-cis-retinal to all-trans-retinal which is bound by opsin. This change triggers a
signal cascade via transducins and phosphodiesterases (PDEs) which ends in depletion of
cellular  cGMP. The resulting closure of  cGMP-gated ion-channels (purple) decreases the Ca2+
uptake. Although the Ca2+ uptake is reduced, the efflux of Ca2+ remains constant which
causes a rapid decline in cellular Ca2+ levels. This results in an instant hyperpolarization of the
cell membrane. In the dark,  cellular  cGMP  and  Ca2+ levels  are  rapidly  restored  and
phototransduction is returned back to the depolarized stage by the phosphorylation of
rhodopsin  which  is  mediated  by  the  recoverin  (Rec)-rhodopsin  kinase  (RK)  complex  and
binding of arrestin. Adapted from Sung and Chuang 2010.
Retinal Pigment Epithelium: Morphology and functions – While photoreceptors have a
single fundamental function i.e. light detection, the RPE is a versatile and indispensable
partner which has multiple functions. There are several morphological and functional
features  which  are  typical  for  the  RPE  such  as  cell  polarization,  retinoid  cycle,
phagocytosis of the POS, tight-junction formation, and melanin pigment formation.
6Polarization can be seen in cellular morphology as well as in apical localization of the cell
organelles such as phagosomes and melanosomes (Futter CE 2006). Polarization is also
observed in localization of RPE-specific proteins such as ezrin and peropsin which are
abundant markers of the apical microvilli (Sun H et al. 1997, Kivelä et al. 2000, Strauss
2005). The apical cell surface facing towards photoreceptors is full of the long microvilli
required for the phagocytosis of POS (Fig. 2) whereas the basal cell membrane next to
Bruch´s membrane (Fig. 1) displays the deep folding essential for the active exchange of
nutrients and other molecules (Marmorstein et al. 1998).
In phagocytosis, decaying proteins and lipids damaged by the sunlight and UV radiation
within the POS are ingested into the RPE. Phagocytosed POS are digested by the
lysosomes (Kevany and Palczewski 2010) as well as by melanosomes which have been
shown to possess similar digestive enzymes as lysosomes (Marmorstein et al. 1998,
Schraermeyer et al. 1999, Futter 2006). Phagocytosis follows a circadian rhythm (Kevany
and Palczewski 2010); this involves several specific proteins such as c-mer proto-oncogene
tyrosine kinase (MERTK), vitronectin receptor v5 and myosin II required for intracellular
trafficking (Futter CE 2006, Kevany and Palczewski 2010). Each RPE cell is responsible for
phagocytosis of POS shed from up to 40 photoreceptors. A single photoreceptor loses
around 10% of its volume every day, which means that enormous amounts of POS must
be ingested during an individuals´ lifespan (Schraermeyer and Heimann 1999, Futter 2006,
Kevany and Palczewski 2010).
The retinoid cycle involves the concerted interaction of the photoreceptors and RPE which
provides the vitamin A derivative, 11-cis retinal for production of opsins. After absorption
of a photon, 11-cis retinal is converted to all-trans retinal and all-trans retinol (Rozanowska
and Sarna 2005). All-trans retinol  is  transported  within  the  shed  POS  or  by  the
interphotoreceptor retinoid binding protein (IRBP) (Strauss 2005, Jin et al. 2009) into the
RPE where the isomerization process back to 11-cis retinal form takes place. An additional
supply of all-trans retinol is provided via the blood circulation into the RPE (Sundaram et
al. 1998, Pfeffer et al. 2004). The majority of the retinal cycle machinery (Table 1.) exists in
the RPE (Gollapalli and Rando 2004, Thompson and Gal 2003a-b) where the cellular
retinaldehyde binding protein (CRALBP) as well as the melanin pigment protect newly
formed retinoids against UV-induced photodegradation (Gonzales-Fernandez 2002). The
reconstituted 11-cis retinal is recycled by IRBP back into the photoreceptors ready for the
initiation of phototransduction. Interestingly, there is some evidence for additional
mechanisms that supplement 11-cis retinal such as the pathway mediated by the retinal G
protein-coupled receptor (RGR) (Chen et al. 2001a-b, Strauss 2005) and a cone-specific
retinoid cycle between the cone and Müller glial cells (Gonzales-Fernandez 2002, Parker
and Crouch 2010).
7Table 1. Retinal proteins required for binding, recycling and conversion of retinoids.
Site of action/protein   Function Reference
photoreceptors
    rod and cone opsins       bind 11-cis-retinal chromophore               Strauss 2005
          (light absorption)  Rozanowska and Sarna 2005
 RDH8, RDH12           reduction of all-trans-retinal to                  Strauss 2005, Parker and Crouch 2010
all-trans-retinol
subretinal space
 IRBP retinoid shuttling between the Strauss 2005
RPE and photoreceptors                 Jin et al. 2009
RPE
 CRBP binds all-trans-retinol                 Strauss 2005
 LRAT esterification of all-trans-retinol               Bok et al. 2003, Strauss 2005
to all-trans retinyl ester Moiseyev et al. 2005
 RPE65 converts all-trans retinyl ester to              Moiseyev et al. 2005
11-cis-retinol
 RDH5, RDH11 11-cis-retinol oxidation to 11-cis-retinal  Strauss 2005, Parker and Crouch 2010
 CRALBP catalyzes 11-cis-retinal formation              Strauss 2005,Gonzales-Fernandez 2002
 RGR           light activated generation of 11-cis-retinal  Chen et al. 2001, Strauss 2005
 RBT/TTR all-trans retinol transport into RPE             Pfeffer et al. 2004
CRALBP = cellular retinaldehyde binding protein, CRBP = cellular retinol binding protein, IRBP =
interphotoreceptor retinal binding protein, LRAT = lecithin retinol acyltransferase, RBT = retinol-binding
protein, RGR = RPE-retinal G protein-coupled receptor, RDH5 = 11-cis retinol dehydrogenases, RDH8 =
all-trans-retinol dehydrogenase 8, RDH11= 11-cis retinol dehydrogenases, RDH12= all-trans-retinol
dehydrogenase 12, RPE65 = 65 kDa isomerohydrolase, TTR = transthyretin
Blood-retinal barrier, tight junctions and active transport – The RPE, Bruch´s membrane
and endothelial cells of choriocapillaries within the choroidea form the blood-retinal
barrier (BRB), a permeability barrier isolating the retina from the systemic circulation
similarly  to  the  blood-brain  barrier  (BBB)  in  the  brain  (Harhaj  and  Antonetti  2004).
Especially, in the retinal vessels and the RPE monolayer, cell-cell junctions are rich in the
tight  junction  proteins  that  are  essential  for  the  barrier  function  such  as  claudins,
junctional adhesion molecyles (JAM), zonula occludens (ZO) family proteins, cadherins
and occludins (Rizzolo et al. 2007, Harhaj and Antonetti 2004, Hamilton et al. 2007). The
presence of this barrier means that active transport across the RPE monolayer is required
for proper nourishment and cellular homeostasis of the retina. Apical microvilli and deep
foldings of the basal surface of the RPE are abundant in transporters and channels, which
are responsible for the delivery of water (Singh and Stewart 2009, Motulsky et al. 2010),
retinoids, nutrients like glucose, amino acids, fatty acids (Mukherjee et al. 2007), ions and
metabolic waste products such as lactic acid produced by photoreceptors (Mannermaa et
al. 2006 and 2009, Strauss 2005).
Melanin pigment and other unique features of the RPE – The RPE and the melanocytes
of the iris and choroidea are heavily melanized. Melanin pigments are synthesized and
packed within melanosomes (Marks and Seabra 2001). Melanin is believed to undertake
8various functions in the eye: it is thought to protect against daylight, UV radiation and
oxidative stress and to have a crucial role in cell differentiation (Sanyal and Zeilmaker
1988, Sarna et al. 2003, Ilia and Jeffery et al. 1999). Details concerning the role of melanin in
the RPE will be described in chapter 2.3.2.
Uniquely, copper, zinc and calcium ions have exceptionally high cellular concentrations in
the retina compared to other tissues (Ulshafer et al. 1990, Grahn et al. 2001, Lengyel et al.
2007). Decreased levels of these metals within the RPE have been shown to associate with
retinal diseases (Wills et al. 2008) such as AMD (Erie et al. 2009). In the RPE, metal ions are
largely bound to melanin (Ulshafer et al. 1990, Hong and Simon 2007). From this storage,
metal ions are supplied to several important metalloproteins in the RPE such as superoxide
dismutase (Zn2+), catalase (Zn2+), retinol dehydrogenase (Zn2+), tyrosinase (Cu2+) and zinc finger
transcription factors (Berg 1990, Dudev and Lim 2003).
Moreover, millimolar concentrations of amino acid taurine (-aminoethanesulfonic acid)
are typically found from the retina and RPE (40-50% of total free amino acids) (Stevens et
al. 1999, Bridges et al. 2001, Militante and Lombardini 2002, 2004). Taurine has activities
related to osmoregulation, antioxidation, neurotransmission and calcium modulation and
depletion of taurine storage has been associated with retinal dysfunction and degeneration
(Militante and Lombardini 2004).
2.1.3 Degenerative diseases of the retina
Retinal disorders which still today lack effective treatment and leading to blindness such
as retinitis pigmentosa (RP), diabetic retinopathy (DR) and age-related macular
degeneration (AMD) affect large numbers of people all around the world. Monogenic
retinal disorders such as RP have a clear genetic etiology, whereas more common diseases
related to aging such as AMD are multifactorial, displaying an association with certain
gene variants and lifestyle factors such as smoking and nutrition. Monogenic disorders are
relatively well characterized with potential candidate genes (Table 2) whereas, typically,
only a few components of the multifactorial disorders are known.
2.1.3.1 Age-related macular degeneration
Age-related macular degeneration (AMD) represents a major healthcare burden for
society. It is the most common cause of untreatable blindness accounting for 50% of all
cases of blindness (3 million persons) in Western countries (Table 2) where  AMD  is
especially common in the aging population (Resnikoff et al. 2004, Scholl et al. 2007; WHO
Vision2020 Action plan 2006-2011). For instance, the prevalence of AMD in the US
population aged over 40 years is 6.5% (Klein et al. 2011) and it is expected to increase
during the coming decades (Rein et al. 2009). AMD  can  be  divided  into  two  disease
subclasses: in dry  AMD  (= geographic atrophy), the functionality of the RPE and
photoreceptors in the macula is slowly disturbed, accompanied by the loss of central
vision. The more severe wet AMD (= neovascular form) is associated with the growth of
new,  leaky  blood  vessels  under  the  macula.  The  dry  form  is  more  common,  with  a
9prevalence of 85-90% in diagnosed patients (Gehrs et al. 2006) whereas the wet form is less
frequent but has a much faster progression. Subsequently, approximately 10-15% of dry
AMD cases will advance to the wet form (Gehrs et al. 2006).
Typically in AMD, the malfunction of the RPE cells and death of photoreceptor cells cause
a gradual loss of sharp central vision at the macula (Hjelmeland 1999, Nowak JZ 2006). In
early AMD, depigmentation of the RPE (Bok D 2005, Scholl et al. 2007, Thompson et al.
2007) and the appearance of extracellular deposits (drusens) located between the RPE and
choroid are typical findings related to the age-related retinal degeneration. In addition, an
accumulation of the “aging pigment”, (lipofuscin), within the RPE is observed (Nilsson et
al. 2003, Gray and Woulfe 2005, Sparrow and Boulton 2005). Moreover, high intracellular
levels of free iron, an inducer of oxidative stress (Hahn et al. 2003, He et al. 2007, Loh et al.
2008), free zinc (Lengyel 2007, Nan et al. 2008, 2011) and the phototoxic fluorophore N-
retinylidene-N-retinyl-ethanolamine (A2E, a  by-product  of  the  retinoid  cycle  and  a
component of the RPE lipofuscin) are typically found in AMD (Sparrow et al. 2003ab,
Lamb and Simon 2004, Sparrow and Boulton 2005). It has been proposed that in the RPE,
majority of the lipofuscin and A2E are originated from the active phagocytosis of the POS,
autophagocytosis (Kaarniranta 2010) and their incomplete digestion in lysosomes (Schütt
et al. 2000) and probably also in melanosomes (Schraermeyer et al. 1999, Biesemeier et al.
2011).
It has been claimed that age-related changes in the RPE melanin are involved in AMD
(Sarna et al. 2003, Binder et al. 2007, Thompson et al. 2007, Rozanowski et al. 2008).
Melanin is a good scavenger of free radicals and it maintains homeostasis of metal ions
within the RPE. When the binding capacity of melanin is exhausted by oxidative stress
and photobleaching, cytotoxic concentrations of redox-active free Fe2+ can be released in
the RPE (Hahn et al. 2006, He at al. 2007, Wolkow et al. 2011). Free Fe2+ is a powerful
initiator of oxidative stress via the Fenton reaction (Galaris and Pantopoulos 2008) as well
as lipid peroxidation (Gutteridge 1995, Cheng and Li 2007) which in part originates from
the continuous phagocytosis of POS. Both oxidative processes are inhibited by melanin
metabolites (Memoli et al. 1997, Sarangarajan and Apte 2004, Zadlo et al. 2007, 2009) which
is proposed to be related with the inverse correlation of melanin levels and lipofuscin
formation in the RPE (Nilsson et al. 2003).
In addition to aging, there are environmental and genetic risk factors associated with
AMD (Tuo et al. 2004, Binder et al. 2007). Exposure to high energy UV radiation, blue light
and oxidative stress caused by smoking and cellular free radicals are generally believed to
be the main factors involved in the cellular damage in AMD (Tuo et al. 2004, Algvere et al.
2006). In addition, prevalence of AMD is associated with ethnic differences, displaying
lower prevalence in black individuals compared to caucasians (odds ratio [OR] 0.37;
confidence interval [CI] 95%, 0.21-0.67, Klein et al. 2011, Bressler et al. 2008, Rein et al.
2009). Although the AMD and the changes in the phenotype of the aged retina have been
relatively well characterized, the understanding of the basic mechanisms of aging process
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at the molecular level is very poor. An estimation of the role of the genetic component
points to about 45% for overall heritability, even higher (71%) for the advanced form of
AMD (Scholl et al. 2007; Sanfilippo et al. 2010).
Several candidate genes for AMD including the complement factor H (CFH), Htra1 serine
peptidase 1 and age-related maculopathy susceptibility 2 have been proposed (Table 2)
(Klein et al. 2005, Scholl et al.2007, Cameron et al. 2007, Francis et al. 2008). For example,
the best characterized single nucleotide polymorphism (SNP) rs1061170 causes an amino
acid  change  in  the  CFH  (Tyr402His)  which  interferes  with  the  binding  of  C-reactive
protein  (CRP)  required  for  complement  activation.  This  CFH  variant  is  one  of  the  few
polymorphisms clearly associated with AMD in Caucasians (Bok D 2005, Gotoh et al.
2006) and it has been shown to be associated with depigmentation of the RPE (Thompson
et al. 2007). CFH controls local inflammation and waste disposal in the cells (Meri 2007,
Laine et al. 2007). In the RPE, oxidative stress and increased cellular levels of free Zn2+
induce aggregation and inhibition of CFH, leading to impairment of the functioning of the
complement system and chronic inflammation (Thurman et al. 2009, Lengyel 2007, Nan et
al. 2008, 2011).
Moreover, as a consequence of the involvement of multiple candidate genes, several
targets for the AMD therapy have been suggested (Petrukhin 2007, Ahmadi and Lim
2008). New anti-VEGF drugs combatting retinal neovascularization such as ranibizumab
(Lucentis, Genentech Inc.) and bevacizumab (Avastin, Genentech) antibodies as wells as
pegylated aptamer pegaptanib (Macugen, OSI/Eyetech) (Ciulla and Rosenfeld 2009,
Kinnunen and Ylä-Herttuala 2011) can reduce the progress of wet AMD. However,
monthly intraocular injections achieve variable results and are required for rest of the life
(van Wijngaarden et al. 2005, Nowak 2006). At the moment, there is no effective treatment
or method for prevention of the dry AMD but antioxidant supplements (zinc, vitamins C
and E, betacarotene) seem to be to some degree effective for advanced AMD as compared
to placebo (OR, 0.72; 99%CI, 0.52-0.98) (Age-Related Eye Disease Study Research Group
2001, Petrukhin 2007, Ahmadi and Lim 2008).
2.1.3.2 Diabetic retinopathy
Diabetic retinopathy (DR), a complication of diabetes mellitus, is one of the most rapidly
increasing  causes  of  blindness  in  the  world.  DR  is  responsible  for  15-17%  of  cases  of
blindness in Western countries (Aiello 2003, WHO Vision2020 Action plan 2006-2011,
Mohamed et al. 2007). The overall estimated heritability of DR varies from 25% to 50%
(Sanfilippo et al. 2010, Grassi et al. 2011). Most of the patients with type 1 or type 2
diabetes will develop DR when their disease progresses. The typical symptoms of DR
include  the  loss  of  microvascular  pericytes,  hemorrhages  in  the  retina  and  abnormal
growth of blood vessels which is probably caused by ischemia in the neural retina and the
RPE (van Wijngaarden et al. 2005, Mohamed et al. 2007, Singh and Stewart 2009, Simo et
al. 2010). As DR progresses, the developing macular edema is the major cause of vision
loss (Singh and Stewart 2009). It is often proposed that vascular endothelial growth factor
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(VEGF) in the choroidea activates a neovascularization cascade that destroys the BRB (van
Wijngaarden et al. 2005, Ng D. 2010). There are also other candidate genes with possible
involvement in DR such as aldose reductase (AKR1B1), angiotensin-I converting enzyme
(ACE), diacylglycerol/protein kinase C (DAG/PKC-) pathway and nitric oxide synthases
(NOS) (Frank 2004, Wilkinson-Berka 2006, Singh and Stewart 2009, Ng D. 2010).
Moreover, there is evidence that decreased expression of IRBP is a cellular indicator of DR
that can be observed at early stages of the disease (Garcia-Ramirez et al. 2009, Simo et al.
2010).
Although different therapies such as photocoagulation are routinely used for DR (Frank
2002),  strict glycemic and blood pressure control is the most efficient way to prevent DR
(Mohamed et al. 2007). Moreover, repeated intravitreal injections of anti-VEGF drugs such
as pegaptanib or anti-VEGF antibodies are approved for use in retinal neovascularization
of DR (van Wijngaarden et al. 2005). In clinical trials, these anti-VEGF drugs have shown
some beneficial effects against the progression of DR and have restored visual acuity
(Nicholson and Schachat 2010).
2.1.3.3 Congenital retinal disorders
There is a heterogenic group of genetically inherited diseases of the retina caused by a
mutation in a single gene. These mutations can be either autosomal recessive or dominant,
or linked to the X chromosome. When compared to the retinal multifactorial diseases such
as AMD and DR, the frequency of monogenic retinal disorders is  low. Although a large
proportion of the monogenic disorders have been well characterized, most of these
diseases are difficult to cure.
2.1.3.3.1 Retinitis pigmentosa
Retinitis pigmentosa (RP) is a heterogenous group of incurable genetic disorders that
impair vision at a young age. The typical signs in RP include night blindness, tunnel vision
in early adulthood and finally blindness (Hartong et al. 2006, Rivas and Vecino 2009).
With the frequency of 1 in 4000, RP is the one of most common inherited retinal disorders
(Hamel C. 2006). So far, about 45 candidate genes have been linked to a common
phenotype of progressive degeneration of photoreceptors that account for around 60% of
the RP cases (Hartong et al. 2006, Radu RA et al. 2008). For instance, mutations in genes for
rhodopsin (10% of all RP cases) and PDE-(3%) that affect the phototransduction process
or for retina-specific ABCA4 transporter (3.5%) involved in the retinoid cycle are relatively
common and well characterized (Hartong et al. 2006, Radu et al. 2008, Biswas-Fiss et al.
2010). Certain mutations of ABCA4 cause RP-related retinal diseases called cone-rod
dystrophy and the Stargardt macular degeneration (Beharry et al. 2004, Hamel C 2007,
Radu et al. 2008, Tsybovsky et al. 2010). Different rare types of the Usher syndrome
(USH1-3) are attributable to mutations in several genes such as myosin 7A (2.5%) and the
Usher syndrome 2A (10%), and have characteristics of RP combined with hearing loss
(Hartong et al. 2006, McGee et al. 2011, Millan et al. 2011).
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2.1.3.3.2 Leber´s congenital amarousis
Leber´s  congenital  amarousis  (LCA) is  a  group of  genetic  disorders  causing blindness  in
children. The frequency is up to 1 in 30 000, accounting for around 5% of all inherited
retinopathies (Chung and Traboulsi 2009). There are 14 known mutations in different
genes responsible for around 70% of LCA cases (den Hollander et al. 2008; Chung and
Traboulsi 2009). Mutations in genes affecting the retinoid cycle and cGMP production such
as retinal pigment epithelium-specific protein 65kDa (RPE65, 6% of all LCA cases) and
retina-specific guanylate cyclase 2 D (12%), respectively, are common causes. In addition,
mutations in the centrosome protein 290 kDa (15%) (den Hollander et al. 2006), and in
genes responsible for photoreceptor structure and cell-specific appearance such as crumbs
homolog 1 (10%) (Graw J 2003, den Hollander et al. 2008, Chung and Traboulsi 2009),
respectively, are often found after an LCA diagnosis. Perhaps the most promising steps
towards vision recovery have been obtained from gene therapy in both animal models and
human LCA patients with a mutated RPE65 form (Acland et al. 2001, Chung and Traboulsi
2009, MacLaren 2009).
2.1.3.3.3 Best vitelliform macular dystrophy
Best vitelliform macular dystrophy (BVMD), also  known  as  a vitelliform macular
dystrophy (VMD2), is a degeneration of the retina caused by different mutations in the
bestrophin-1 (BEST1) gene (Strauss 2005, Hartzell et al. 2008, Marmorstein et al. 2009). The
prevalence of BVMD is unknown. BEST1 is a transmembrane protein expressed in the
RPE, where it has been proposed to function either as a Ca2+-activated chloride ion channel
or as a regulator of ion channels (Hartzell et al. 2008). As in AMD, the accumulation of
lipofuscin pigment is often observed in BVMD patients. It seems that a malfunction of
BEST1 also affects ion transport from photoreceptors to the RPE which is reflected as an
increased fluid volume in the subretinal space. This could explain the retinal detachments
that are commonly observed in BVMD (Hartzell et al. 2008).
2.1.3.3.4 Visual dysfunctions related to pigmentation
Albinism is caused by lack of melanin production in pigmented cells in skin, hair and the
eye  (oculocutaneous  albinism,  OCA)  or  specifically  in  the  eye  (ocular  albinism,  OA)
(Oetting and King 1999, Young TL 2003). The prevalence of OCA is about 1 in 17 000
(Grønskov et al. 2009) whereas the estimated frequency of OA is much lower, about 1 in
50 000 persons (Chong et al. 2009). Although over 100 genes are involved in pigmentation
(Ganesan et al. 2008, Schiaffino 2010), only a few of them are associated with albinism.
These include tyrosinase (TYR) in oculocutaneous albinism type 1 (OCA1),
oculocutaneous albinism gene 2 (OCA2), tyrosinase-related protein 1 (TYRP1) (OCA3),
solute carrier SLC45A2 (OCA4) and G protein-coupled receptor 143 (GPR143) in ocular
albinism type 1 (OA1) (Oetting and King 1999; Marks and Seabra 2001; Albinism database:
http://albinismdb.med.umn.edu/). Affected albino individuals have impaired vision and
developmental abnormalities in the retina (Gimenez et al. 2004 and 2005, Thomas et al.
2005, Oetting and King 1999). Their visual acuity is altered due to the decreased number of
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ganglion cells and uncrossed axonal projections to the brain (Rachel et al. 2002, von dem
Hagen et al. 2005, Lavado and Montoliu 2006).
These dysfunctions are thought to be related to lack of melanin pigment or its
intermediate products such as L-dihydroxyphenylalanine (L-DOPA) (Thomas et al. 2005).
Mouse models have revealed that a threshold level of 35% in tyrosinase activity is needed
for normal retinal development (Rachel et al. 2002).
Choroideremia (CHM) is a rare (1 in 50 000) X-linked degeneration of the retina where all
layers of the retina are severely affected (MacDonald et al. 2009). CHM is typically found
in males, but due to inactivation of the X-chromosome, the mosaic appearance of
degeneration is also observed in female carriers (Perez-Cano et al. 2008).  Mutations in the
Rab escort protein-1 (REP1) are common in CHM patients and it has been shown that
geranylgeranylation of Ras-associated binding proteins (RABs) is affected by loss of REP1
(Corbeel and Freson 2008). In RPE, a GTPase protein called RAB27a is involved in
trafficking of melanosomes. Thus, similar defects has been observed in a conditional REP1
knockout mouse model (Tolmachova et al. 2006) and mutant mouse lacking Rab27a
(Lopes et al. 2007a). Both mouse models exhibit malfunctions in melanosome trafficking,
and display depigmentation and degeneration of the RPE.
Structural ocular malformations, microphthalmia (small eye) and anophthalmia (loss of
eye) are commonly linked with mutations in retina-specific transcription factors
responsible for proper eye development and melanogenesis. These factors include the
microphthalmia-associated transcription factor (MITF), orthodenticle homeobox protein 2
(OTX2), paired box protein 6 (PAX6) and SRY-box 2 (SOX2) (Hever et al. 2006, Schilter et
al. 2011). The estimated frequency of ocular malformations is around 1-2 in 10 000 (Hever
et al. 2006). The Waardenburg syndrome 2 (WS2) and Tietz syndrome are a heterogenic
group of diseases (Dessinioiti et al. 2009) which manifest with deafness, abnormal
pigmentation in skin, hair and the eye (Tassabehji et al. 1994). Certain forms of these
syndromes display retinal depigmentation and dysfunction and these are associated with
mutations in MITF (Morell et al. 1997, Smith et al. 2000, Levy et al. 2006, Izumi K 2008,
Chiang et al. 2009, Pingault et al. 2010).
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2.2 REGULATION OF GENE EXPRESSION IN THE RETINA
In a single gene, the regulatory regions responsible for transcription are mainly found in
the non-coding regions of the gene. Especially, DNA regions upstream of the transcribed
mRNA sequence called promoters are crucial for gene expression. The promoter controls
the activity of gene expression in a temporal and spatial manner which is mediated by
cell-specific DNA-binding proteins called transcription factors and their co-regulators. In
addition to the proximal promoter region, more distal regulatory regions called enhancers
and silencers are typically involved in gene expression (Bulger and Groudine 2010).
2.2.1 Retina-specific regulation of gene promoters
Expression of retinal transcription factors is required for the development of different
retinal layers during the embryogenesis as well as for maintenance of the differentiated
phenotype of the retina (Graw 2003, Hennig et al. 2008). Mutations in these factors are
associated with retinal disorders such as LCA (Chung and Traboulsi 2009, Henderson et
al. 2009) or even more severe malformations of the eye such as microphthalmia or
anophthalmia (Verma and FitzPatrick 2007, Swaroop et al. 2010).
In the retina, the master regulators responsible for retinal development such as PAX6,
OTX2, COUP transcription factors 1 and 2 (NR2F1 and 2F2) are expressed ubiquitously in
the neural retina and the RPE. Lower in the regulatory hierarchy, a group of retina-specific
transcription factors (Table 3) are believed to be responsible for activation of retinal gene
promoters and specification of retinal cell types from the multipotent retinal progenitors
(Ohsawa and Kageyama 2007, Swaroop et al. 2010). Retinal progenitors are tightly
controlled by the NOTCH signalling pathway responsible for the differentiation of retinal
neurons (Ohsawa and Kageyama 2007, Swaroop et al. 2010). Down-regulation of the
NOTCH pathway enables specification of the neural retina, and retinal ganglion cells
(RGCs)  are  the  first  retinal  neurons  to  be  specified  in  the  presence  of  factors  PAX6  and
atonal homolog 7 (ATOH7). Later, OTX2, cone-rod homeobox protein (CRX) and neural
retina leucine zipper (NRL) are required for photoreceptor specification with co-operation
of homeodomain factors and nuclear receptors (see Table 3) preferentially expressed in
the retina (Donner and Maas 2004, Wang et al. 2004, Peng et al. 2005, Cheng et al. 2006,
Ohsawa and Kageyama 2007, Hennig et al. 2008). The differentiation and melanization of
the  RPE are  regulated by Wnt/-catenin- and cAMP-dependent signalling pathways and
factors such as OTX2 and MITF (Martinez-Morales et al. 2004, Westenskow et al. 2009,
Beby et al. 2010).
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Table 3. Transcription factors responsible for retinal development and differentiation.
Cell type Transcription
 factor type factor Site of action (function) Reference
CRX photoreceptor differentiation Hennig et al. 2008, Swaroop et al. 2010
En1/2 RGC axon guidance Brunet et al. 2005,
LHX2 optic vesicle formation Nguyen and Arnheiter 2000
OTX2 photoreceptor differentiation Nishida et al 2003, Martinez-Morales et al. 2003,
Hever et al. 2006, Swaroop et al. 2010
PAX2/6 optic vesicle formation Hever et al. 2006, Danno et al. 2008,
neural retinal progenitors  Swaroop et al 2010, Tang et al. 2010
QRX neural retinal differentiation  Wang et al. 2004
RAX optic vesicle/Muller cell formation Voronina et al. 2004, Danno et al. 2008
SIX3/6 neural retinal progenitors Donner and Maas 2004, Oshawa and Kageyama 2007
SOX2 neural retinal progenitors Danno et al. 2008, Hever et al. 2006, Yang et al. 2009
VAX1/2 optic vesicle formation Mui et al. 2005, Tang et al. 2010,
VSX2 neural retinal progenitors Rowan and Cepko 2004, Swaroop et al. 2010
bipolar cells Oshawa and Kageyama 2007
COUP-TF1/2 cone cell differentiation Swaroop et al. 2010
PNR rod cell differentiation Cheng et al. 2006, Swaroop et al. 2010
ROR cone cell differentiation Swaroop et al. 2010
RXR cone cell differentiation Swaroop et al. 2010
TR2 cone cell differentiation Swaroop et al. 2010
TLX neural retinal differentiation Yu et al. 2000, Kobayashi et al. 2000
ATOH7 RGC differentiation Feng et al. 2010, Oshawa and Kageyama 2007,
HES1 and 5 neural retinal progenitors Morrow et al. 1998, Swaroop et al. 2010
NEUROD1 photoreceptor differentiation Oshawa and Kageyama 2007, Swaroop et al. 2010
amacrine cell differentiation
           FOXN4 neural retinal progenitors Li et al. 2004, Oshawa and Kageyama 2007,
NRL rod cell differentiation Swaroop et al. 2010, Hennig et al. 2008
OTX2 differentiation, melanogenesis Martinez-Morales 2003, Hever et al. 2006,
PAX2/6 optic vesicle formation Bäumer et al. 2003, Hever et al. 2006
SOX9 RPE differentiation Masuda and Esumi 2010
           NR2F1/2  RPE differentiation Tang et al. 2010
MITF(A,D,H,J)  differentiation, melanogenesis Amae et al. 1998, Martinez-Morales et al. 2004,
Bharti et al. 2008
-catenin  Wnt-pathway/melanogenesis Westenskow et al. 2009, Fujimura et al. 2009,
RPE  =  retinal  pigment  epithelium,  RGC  =  retinal  ganglion  cell,  HD  =  homeodomain  protein,  NR  =  nuclear  receptor,
bHLH = basic-Helix-Loop-Helix protein, FH = forkhead protein, LZ = leucine zipper protein, ATOH7 = atonal homolog 7
(Drosophila), COUP-TF1/2 (NR2F1/2) = COUP transcription factor 1/2, CRX = cone-rod homeobox protein, EMX1/2 =
empty spiracles homeobox protein, En1/2 = Engrailed 1/2, FOXN4 =  forkhead box protein N4, HES1 = hairy and
enhancer of split 1, HES5 = hairy and enhancer of split 5, LHX2 = lim-homeodomain protein, MITF = microphthalmia-
associated protein, NEUROD1 = neurogenic differentiation factor 1, NRL = neural retina leucine zipper protein, PNR
(NR2E3) = photoreceptor-specific nuclear receptor, OTX1/2 = orthodenticle homeobox 1/2, PAX6 = paired box protein 6,
QRX (RAX2) = retina and anterior neural fold homeobox 2, ROR(NR1F1/NR1F2) = RAR-related orphan receptor
alpha/beta, RAX = retina and anterior neural fold homeobox, RXR(NR2B3) = retinoid X receptor-, SIX3/6 = retinal
homeobox protein 3/6, SOX2/9 = SRY-box 2/9, TLX (NR2E1) = tailless orphan nuclear receptor, TR2 (NR1A2) = thyroid
hormone receptor 2, VAX1/2 = ventral anterior homeobox 1/2, VSX2 (CHX10) = visual system homeobox 2.
  bHLH
NR
Neural
Retina
RPE
FH
LZ
HD
       NR
     bHLH
       armadillo
HD
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2.3 REGULATION OF THE HUMAN TYROSINASE IN RPE
Melanin is synthesized in three different cell types: melanocytes, RPE and pineal cells
which arise from different developmental origins of neural crest, neuroectoderm and
diencephalon, respectively (Sato and Yamamoto 2001). While the neuroectodermal RPE
cells are found only in the retina, melanocytes are abundant in the skin, hair root, inner
ear, and in choroidea and iris of the eye (Benedito et al. 1997, Plonka et al. 2009, Sato and
Yamamoto 2001). Interestingly, melanin pigment is found also in the brain in the
substantia nigra, pineal gland and locus ceruleus; in these sites it is called neuromelanin
(Double 2006, Zecca et al. 2008, Bush et al. 2009).
2.3.1 Biosynthesis of melanin within melanosomes
In pigmented cells, biosynthesis of the melanin pigment (melanogenesis) takes place
within melanosomes. Melanosomes exhibit similarities with endosomes and lysosomes
(Raposo and Marks 2007) but they also express unique proteins such as tyrosinase (TYR),
tyrosinase-related protein 1 (TYRP1) and dopachrome tautomerase (DCT; also known as
tyrosinase-related protein 2 (TRP-2)). These genes are required for melanogenesis (Fig. 4)
and are highly conserved across the animal kingdom (Olivares and Solano 2009). In the
tyrosinase gene family, TYR (EC 1.14.18.1) is the rate-limiting protein responsible for
melanin biosynthesis (Ray et al. 2007). TYR binds copper by coordination to histidine
residues to form active domains for its substrates tyrosine and L-dihydroxyphenylalanine
(L-DOPA) (Wang and Hebert 2006). Tyrosine is obtained either from the diet or it can be
synthesized from phenylalanine by the cytosolic enzyme, phenylalanine hydroxylase
(PAH) (Schallreuter et al. 2008). In melanogenesis (Fig. 4), L-DOPA and other
intermediates of melanin such as L-dopaquinone, L-cysteinyldopa, 5,6-dihydroxyindole
(DHI) and 5,6-dihydroxyindole-2-carboxylic acid (DHICA) are synthesized by TYR from
tyrosine with contributions of TYRP1 and DCT (Simon et al. 2008). These intermediates are
finally  polymerised  to  two  forms  of  melanin,  eumelanin  and  pheomelanin  (Simon  et  al.
2008 and 2009 review). Black or brownish eumelanin is a copolymer of DHI and DHICA
whereas reddish or yellow pheomelanin is composed of 1,4-benzothiazines (Fig. 4).
In the brain, catecholamines such as dopamine and the intermediate L-DOPA are
synthesized from tyrosine by tyrosine hydroxylase (TH) (Asanuma et al. 2003). There is
some evidence that TYR and TH can substitute for each other in L-DOPA synthesis (Rios
et al. 1999, Higashi et al. 2000, Asanuma et al. 2003, Eisenhofer et al. 2003, Schallreuter et
al. 2008). It is proposed that TYR and TH work in harmony in the melanosomal membrane
where  TH  initiates  L-DOPA  synthesis  in  early  stage  melanosomes  at  low  pH.  This  is
followed by melanin synthesis within the mature melanosomes at higher pH (6.8) which is
optimal for TYR (Schallreuter et al. 2008). TYR, TH and PAH all require
tetrahydrobiopterin (BH4) as their cofactor (Schallreuter et al. 1999, Schallreuter et al.
2008).
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Figure 4. Biosynthesis  of  L-DOPA  and  the  two  most  common  forms  of  melanin  found  from
mammals, eumelanin and pheomelanin. Reactions in melanogenesis are catalyzed by the
melanogenic enzymes or by auto-oxidation of the intermediate products. Both, tyrosinase and
tyrosine hydroxylase can synthesize L-DOPA and they may substitute for each other or work
together depending on tissue type (Modified from Asanuma et al. 2003).
After post-translational modifications in ER and Golgi apparatus, TYR, TYRP1 and DCT
are sorted into melanosomal lipid layer where they form the melanogenic enzyme
complex. The formation and activation of this complex are assisted by the protein kinase C
beta (PKC-)-  mediated phosphorylation of  TYR  (Wang and Hebert  2006,  Wu and Park
2003, Francis et al. 2003). Melanosomes go through four developmental stages from
depigmented, stage I early endosomes to heavily pigmented, mature stage IV
melanosomes (Raposo and Marks 2007). Melanogenesis is most active in stage III and IV
melanosomes (Watabe et al. 2004, Wang and Hebert 2006, Raposo and Marks 2007). TYR,
TYRP1 and DCT have transmembrane domains and their catalytically active domains are
located within the melanosome where the synthesized melanin is deposited onto
melanosomal fibrils (Fig 5.) (Raposo and Marks 2007, Leonhardt et al. 2011). These fibrils
are mainly formed at early stages from cleavage of the melanosomal transmembrane
protein PMEL17 by the proprotein convertase (PC).
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Regulation of melanogenesis – Melanogenesis is a complex process known to involve
over 100 genes (Ganesan et al. 2008, Schiaffino 2010) involved in cell signaling and cellular
machinery responsible for synthesis, modifications and sorting of melanosomal proteins
(Fig. 6). The hormonal regulation of melanogenesis is mediated by melanocortins such as
the -melanocyte stimulating hormone (-MSH) and agouti signaling peptide (ASIP)
(Rouzaud et al. 2005, Yamaguchi and Hearing 2009). The peptide hormone -MSH is
cleaved from pro-opiomelanocortin (POMC) and adrenocorticotrophic hormone (ATCH)
synthesized by the pituitary gland in brain and in skin keratinocytes (Catania 2008,
Wasmeier et al. 2008). There are five melanocortin receptors belonging to the superfamily
of G-protein coupled receptors (GPCRs)(Luttrell LM 2008). Of these, the melanocortin-1
receptor (MC1R) is involved in regulation of melanogenesis (Garcia-Borron et al. 2005).
The MC1R gene is exceptionally polymorphic having around 60 codon substitutions which
are mainly enriched in the white population with fair skin and red hair phenotypes
(Garcia-Borron et al. 2005). Activation of MC1R by -MSH activates adenylate cyclase and
finally cAMP response element-binding protein (CREB) which has specific binding sites in
20
the MITF gene promoter (Steingrimsson et al. 2004, Cheli et al. 2010). This is the pathway
(Fig. 6) through wich -MSH can activate MITF and its melanogenic target genes
including TYR (Table 4). Transcription and activity of MITF and melanogenesis are
further regulated by the phosphatidylinositol 3-kinase and Wnt/-catenin pathways
(Widlund and Fisher 2003). Wnts are secreted signaling proteins involved in retinal
development and differentiation but they also have a role in retinal disorders and cancer
(Lad et al. 2009). The proto-oncogene c-Kit -mediated MAP kinase pathway is a well
known regulator of melanogenesis particularly in melanocytes but whether it has a similar
role in the RPE is unclear. On the other hand, the c-Kit pathway is involved in retinal
development (Koso et al. 2007).
Figure 6. Schematic presentation of the melanogenic signaling pathways in the RPE cell based
on information collected from studies in mammals. Activation of  MC1R by -MSH on the cell
surface triggers the adenylate cyclase, the PKA pathway, and finally, expression of MITF gene
which  is  transactivated  by  binding  of  CREB  (Sciaffino  2010).  MITF  has  several  target  genes
that are involved in melanin synthesis including genes within the TYR family. In addition,
MC1R-mediated  regulation  of  melanogenesis  is  modulated  via  PI3K/AKT-  and  Wnt/-catenin
pathways (Burke 2008). The MC1R-mediated signaling is inactivated by its antagonist ASIP or
hydrolysis  of  cAMP  by  PDEs.  AC=adenylate  cyclase,  AKT=  serine/threonine  protein  kinase,
ASIP=agouti signaling peptide, CRE=cAMP response element, CREB=cAMP response element-
binding protein, DCT=dopachrome tautomerase, FRZ=frizzled receptor, Gs=G proteins,
GSK3b=glycogen synthase kinase 3 beta, LEF1=lymphoid-enhancing factor 1,
MC1R=melanocortin  receptor  1,  MITF=microphthalmia-associated transcription factor,
PAX2/6=paired box protein 2 and 6, PDE=phosphodiesterase, PI3K=phosphatidylinositol 3-
kinase, PK=protein kinase A, POMC=pro-opiomelanocortin, SP-1=specificity protein-1,
TDE=tyrosinase  distal  element,  TYR  =tyrosinase,  TYRP-1=tyrosinase  related  protein  1.
Partially adapted from Sciaffino 2010.
21
In addition, 	MSH and cAMP regulate the intracellular and the intramelanosomal pH
which are crucial for the sorting and also the activity of melanosomal enzymes such as
TYR (Watabe et al. 2004, Wang and Hebert 2006). The cellular machinery within the
endoplasmic reticulum, Golgi apparatus and early endosomes is able to arrange the
melanosomal enzymes into melanosomes (Wasmeier et al. 2008, Theos et al. 2005). This
process requires proper post-translational modification of the melanosomal proteins such
as glycosylation and phosphorylation (Watabe et al. 2004).
2.3.2 Role of tyrosinase and melanin in the development and physiology of the eye
In  contrast  to  the  skin  melanocytes  which  synthesize  and  transport  melanin  into
keratinocytes continuously through the lifespan (Wasmeier et al. 2008), the majority of
melanin pigment in the RPE is synthesized during embryonic and neonatal development
(mouse, embryonic day 10.5 to post-natal day 8) and stored for the life-time within
melanosomes (Smith-Thomas et al. 1996, Page-McCaw et al. 2004, Lopes et al. 2007b,
Gargiulo et al. 2009). In the eye, TYR, melanin and its intermediate products are required
for proper development and function of the RPE and neural retina (Ilia and Jeffery et al.
1999, Page-McCaw et al. 2004, Lavado et al. 2006, Lopez et al. 2008, Gargiulo et al. 2009).
For instance, albino individuals lack melanin and they display abnormally developed
retinas and misprojected retinal ganglion cell axons that affect binocular vision (Oetting
and King 1999, Lavado and Montoliu 2006, Rachel et al. 2002a-b, Cronin et al. 2003,
Gimenez et al. 2001, 2004, 2005). In addition, albinos suffer from photophobia i.e. even
ordinary exposure of daylight is extremely uncomfortable, and prolonged exposure leads
to accelerated degeneration of the retina (Ray et al. 2007, Gargiulo et al. 2009).
Interestingly,  L-DOPA  is  an  endogenous  ligand  for  the  GPCR  protein  GPR143  which  is
located in melanosomal membranes (Lopez et al. 2008). GPR143 is proposed to control the
maturation of the melanosomes and the activity of secreted pigment epithelium-derived
factor (PEDF) involved in retinal development (Lopez et al. 2008, Sciaffino MV 2010).
PEDF possesses neurotrophic, neuroprotective and anti-angiogenic properties within the
retina (Wong WT et al. 2004). This links TYR tightly to regulation of the retinal
development.
Melanin is also required for long-term maintenance of the normal retina as a protective
screen against sunlight and UV radiation (Sanyal and Zeilmaker 1988, Sarna et al. 2003,
Hu et al. 2008). In the RPE, this is supported by a light-dependent melanosome trafficking
system via  the  microtubular  network which is  controlled by two motor  proteins,  kinesin
(towards periphery) and dynein (to center) (Wasmeier et al. 2008). At the apical periphery
of the RPE, melanosomes are transported via the actin network by the protein complex of
small GTPase Rab27a, myosin VIIaA and their interacting protein MyRIP (Futter CE 2006,
Lopes et al. 2007a). This machinery follows the circadian rhythm and is proposed to utilize
the same trafficking system as POS phagocytosis (Futter CE 2006). In addition, cellular
homeostasis  of  metal  ions  and  oxidative  stress  is  extensively  controlled  by  the   melanin
content (see chapter 2.1.3.1).
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2.3.3 Regulation of the human tyrosinase promoter
Specific transcription factors are tightly involved in the regulation of melanogenesis. The
role of these specific transcription factors in the regulation of tyrosinase, TYRP-1 and DCT
has been extensively studied in melanocytes (Murisier and Beermann 2006) but less
information is available from the RPE and pigmented cells of the brain. For instance,
transcription factors from the MITF family and other factors such as specificity protein 1
(SP1), paired box protein 3 (PAX3), SRY-box 10 (SOX10) and lymphoid-enhancing factor 1
(LEF1) are known regulators of melanogenic genes in mouse and human melanocytes
(Murisier and Beermann 2006). In human RPE, TYR, TYRP1 and DCT promoters are
activated by MITFs (Murisier and Beerman 2006) and OTX2 has been shown to activate
TYRP1 and DCT expression (Fig.7) (Martinez-Morales et al. 2003, Takeda et al. 2003,
Murisier and Beerman 2006). In melanocytes, the best studied pathway for activation of
melanogenesis is mediated by the MC1R and cAMP pathways which involve also Wnt/-
catenin signaling (Fig. 6) (Schepsky et al. 2006, Burke JM 2008, Fujimura et al. 2009).
Activation of the melanogenic genes via cAMP is mediated by the protein kinase A (PKA),
and CREB transcription factors able to bind to the CRE elements (TGACGTCA) found in
target genes such as MITF-M (Park et al. 2006, Hallsson et al. 2007). However, CRE
elements are not found in promoter regions of melanogenic target genes such as TYR,
TYRP1 or MC1R (Park et al. 2006, Moro et al 1999).
Figure 7. Previously identified regulatory elements in the human TYR, TYRP-1 and DCT
promoters.  Binding  sites  for  MITF  are  present  in  every  member  of  the  tyrosinase  family
whereas binding sites for OTX2 have been described in TYRP1 and DCT (Murisier and
Beermann 2006). MITF transcription factors bind to E-box, M-box and TDE elements whereas
the presence of a conserved enhancer element has been documented but its specific binding
sites  have  not  been  identified.  The  bent  arrow  indicates  the  initiation  site  of  transcription
(position +1).
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In the human TYR promoter (Fig.  7), two CATGTG-like MITF binding elements (E-box
and M-box) are positioned at the proximal promoter near the transcription initiation site
and the third MITF element (TDE) is located about 1.8 kb upstream (Yasumoto et al. 1997,
Murisier and Beermann 2006). In addition, a more distal enhancer element -8 to – 10 kb
upstream was shown to be active in melanocytes (Fryer et al. 2003, Regales et al. 2003,
Murisier and Beerman 2006). The human TYRP-1 promoter contains one MITF binding
element (M-box) (Yasumoto et al.  1997) and two inverted OTX2 binding sites (GGATTA)
(Martinez-Morales et al. 2003). In the human DCT promoter, one OTX2 binding site
(CTAATCCC) and two MITF sites (M-box and E-box) are found near the initiation site of
transcription (Yasumoto et al. 1997, Bertolotto et al. 1998, Takeda et al. 2003).
2.3.4 Microphthalmia-associated transcription factors
In humans and mice, the family of MITF consists of 9 isoforms (Fig. 8) each representing a
unique N-terminal part coded by separate first exons and sharing common exons 2-9
(Levy et al. 2006, Bharti et al. 2008). Interestingly, the promoter regions are unique for each
isoform, enabling tissue-specific control of gene expression (Bharti et al. 2008) which is
regulated by the transcription factors such as -catenin, LEF1, PAX2 and PAX6 (Udono et
al. 2000, Bäumer et al. 2003, Bharti et al. 2008, Westenskow et al. 2009). The isoform MITF-
M  is  expressed  in  melanocytes  whereas  other  forms  such  as  MITF-A  and  –J  are  more
abundant in the retina and other tissues (Amae et al. 1998, Hershey and Fisher 2005, Bharti
et al. 2008). Isoforms MITF-H and –D are restricted to the RPE and have a more important
role during the developmental phase of the retina (Takeda et al. 2002, Bharti et al. 2008).
MITFs belong to the myc family  of  basic  helix-loop-helix-leucine zipper (bHLH-LZ)
transcription factors which recognise the E-box sequence (CANNTG) (Rishi et al. 2004,
Hallsson et al. 2007, Cheli et al. 2010). MITFs can self-dimerize but display no tendency to
dimerize with other bHLH-LZ transcription factors (Hallsson et al. 2007, Meadows et al.
2007). MITFs are well-known master regulators of melanogenesis (Table 4) (Aoki  and
Moro 2002, Du et al. 2003, Cheli et al. 2010). Interestingly, there is a broad array of MITF
target genes outside the pigmentation machinery such as a group of genes involved in
osteoclast differentiation and function (Cassady et al. 2003, Hershey and Fisher 2004,
Meadows et al. 2007, Ripoll et al. 2008). The role of MITFs in regulation of melanogenesis,
cell specification/differentiation and maintenance of cell differentiation has been
systematically studied in mutant mouse models (Levy et al. 2006, Bharti et al. 2008).
Moreover, a significant role for MITFs in the development of the eye, skin and ear
melanocytes is indicated by the association of MITF mutants with developmental
malformations of the eye (Graw J 2003), pigmentary abnormalities of the skin and
inherited hearing loss, respectively (Tassabehji et al. 1994).
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Table 4. Proposed target genes and protein-protein interaction partners of the MITF in the eye.
Gene Site of expression  Protein function Reference
TYR  melanocytes/RPE melanogenesis Murisier and Beermann 2006
TYRP-1  melanocytes/RPE melanogenesis Murisier and Beermann 2006
DCT melanocytes/RPE melanogenesis Murisier and Beermann 2006
GPR143  melanocytes/RPE melanosome structure Vetrini et al. 2004
receptor for L-DOPA Lopez et al. 2008
MC1R  melanocytes/RPE -MSH receptor Moro et al 1999, Aoki and Moro 2002
PMEL17  melanocytes, RPE melanosome structure Du et al. 2003
MLANA  melanocytes, RPE melanosomal protein Du et al. 2003
RAB27A  RPE melanosome transport Kawasaki et al. 2007,
Chiaverini et al. 2008
PKC-  melanocytes TYR phosphorylation Park et al. 2006
p300  melanocytes, co-activator Stengrimsson et al. 2004
LEF1  melanocytes/retina  transcription factor Yasumoto et al. 2002,Saito et al. 2002,
-catenin melanocytes/RPE co-activator Schepsky et al. 2006
PAX2/6  RPE MITF co-repressor Planque et al. 2001,
Marinez-Morales et al. 2004
OTX2  RPE transcription factor Martinez-Morales et al. 2003,
Masuda and Esumi 2010
SOX9  RPE transcription factor Masuda and Esumi 2010
-MSH  = -melanocyte  stimulating  hormone,  DCT  =  dopachrome  tautomerase,  GPR143  (OA1)  =  G  protein-
coupled  receptor  143,  LEF1  =  lymphoid-enhancing  factor  1,  MLANA  (MART1)  =  melanoma  antigen,  MC1R  =
melanocortin  receptor  1,  OTX2 = orthodenticle  homeobox 2,  PAX2/6 = paired box protein  2  and 6,  PKC- =
protein kinase C beta, PMEL17 = premelanosome protein, p300 = E1A binding protein p300, RAB27A = GTPase
RAB27A, SOX9 = SRY-box 9, TYR = tyrosinase, TYRP-1 tyrosinase related protein 1.

Functional domains of MITF – The conserved domains of the MITF are well characterized
(Fig. 8). The bHLH-LZ domain for DNA binding and dimerization is common between the
isoforms and highly conserved (85-100%) in mammals (Hallsson et al.2007). In addition,
three potential activation domains AD1, 2 and 3 for target gene activation are found
within the common exons 2 to 9 (Hallsson et al. 2007). An additional activation domain
AD4 is proposed to reside in the N-terminus of the isoform MITF-A (exon 1A) (Hallsson et
al. 2007). The best characterized activation domain (AD1) N-terminal to the bHLH domain
is known to interact with the p300 co-activator protein (Hallsson et al. 2007, Sato et al.
1997, Goding 2000) which has histone acetyltransferase activity required for chromatin
remodelling. In addition, there are other potential interacting domains and multiple
conserved sites for post-translational modification such as sites for serine phosphorylation
and SUMOylation identified in the mouse (Hallsson et al. 2007).
Mutations in the MITF bHLH domain occur in Waardenburg and Tietz syndromes which
present with depigmentation, ocular malformations and deafness. These mutations alter
DNA binding and dimerization of MITF. Other mutations in these diseases have been
found in the genes coding for PAX3 and SOX10 that regulate MITF levels (Tassabehji et al.
1994, Morell et al. 1997, Izumi et al. 2008, Chiang et al. 2009).
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Figure 8. MITF isoforms (A, J, H and D) and their functional domains. Exons 2-9 of MITF are
identical in all isoforms except for the 18 additional bases in the exon 6 of the MITF-M isoform.
The promoter and exon 1 (X-B1b) are unique for  each isoform. The isoforms MITF-A, -J,  -H
and –D are mainly expressed in the retina and the RPE whereas MITF-M is melanocyte-specific.
The conserved and common domains are shown relative to the corresponding amino acids. Out
of four putative activation domains (AD1-4) in MITFs, AD1 is the best characterized. The basic
helix-loop-helix-leucine zipper  (bHLH-LZ)  domain  for  DNA  binding  and  MITF  dimerization  is
highly conserved between species as is  the serine-rich C-terminal  domain (S).  Adapted from
Udono et al. 2000, Hallsson et al. 2007.
2.3.5 Orthodenticle homeobox 2 transcription factor
In humans, the family of OTX transcription factors contains four members, OTX1-3 and
the OTX-related CRX (Acampora et al. 2000, Zhang 2002). They belong to the bicoid
subfamily of homeodomain transcription factors that share a highly conserved
homeodomain responsible for DNA binding. These factors are essential for development
and differentiation of forebrain, midbrain and the retina (Acampora et al. 2000, Boyl et a.
2001, Simeone et al. 2002). For instance, the mouse model, knock-down of OTX2 is fatal,
since it dramatically affects the development of the forebrain (Koike et al. 2007).
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In the retina, both, OTX2 and CRX are expressed in the neural retina and the RPE whereas
OTX1 is not found in either tissue (Esumi et al. 2008). OTX2 is present in the multipotent
retinal progenitor cells involved in retinal development (Koike et al. 2007, Swaroop et al.
2010). In addition, OTX2 is one of the master regulators required for differentiation and
maintenance of the retinal phenotype. In photoreceptors, OTX2 is a known activator of
gene promoters of interstitial retinoid-binding protein (IRBP)(Bobola et al. 1999, Fong and
Fong 1999, Chatelain et al. 2006) and CRX which is responsible for the regulation of the
opsins (Henderson et al. 2009). Notably, OTX2 is not transcribed in retinal ganglion cells
(RGC) but transported to these cells from the bipolar cells that express OTX2 (Rath et al.
2007, Koike et al. 2007, Swaroop et al. 2010). In the RPE, mouse Tyr, human DCT and
BEST1 promoters have been shown to be regulated by OTX2 (Martinez-Morales et al. 2003,
Takeda et al. 2003 and Esumi et al. 2009). Substantial role for OTX2 in RPE pigmentation
and retinal development is well established in animal models (Koike et al. 2007,
Westenskov et al. 2009) such as the conditional Otx2 knockout mouse (Nishida et al. 2003,
Beby et al.  2010).  In humans, mutations of OTX2 are linked to ocular malformations and
retinal disorders (Ragge et al. 2005, Verma and FitzPatrick 2007, Tajima et al. 2009,
Henderson et al. 2009, Dateki et al. 2010, Schilter et al. 2011).
In brain, OTX2 is a typical marker of the dopaminergic neurons (Vazin et al. 2008, Di
Salvio et al. 2010) and it is involved in their development and survival (Omodei et al.
2008). In Otx2 null mice, there are disturbances in the differentiation of dopaminergic
neurons (Omodei et al. 2008) and they typically display a reduced number of TH -positive
cells (Borgkvist et al. 2006) that are responsible for synthesis of the catecholamine
neurotransmitters.  In  addition,  OTX2  is  found  in  the  pineal  (Nishida  et  al.  2003)  and
pituitary glands (Diaczok et al. 2008). Moreover, OTX2 regulates the expression of the
gonadotropin-releasing hormone gene in the hypothalamus (Kelley et al. 2000, Larder and
Mellon 2009). Some mutations of OTX2 have been related to malformation of these tissues
as well as to an increased risk of hypopituitarism with altered hormonal homeostasis
(Dateki et al. 2008, 2010, Diaczok et al. 2008, Tajima et al. 2009, Alatzoglou and Dattani
2009). Due to its important role in hormone homeostasis in brain, mutations in OTX2 are
detrimental for embryonic development and also cause multiple malformations
throughout the body.
Functional domains of OTX2 – So far, two OTX2 transcript variants have been found. The
longer isoform A (NM_021728) contains 5 exons whereas isoform B (NM_172337) is
truncated from the 5´-terminus, having only common exons 3 to 5 which are translated in
both isoforms. Between the translated isoforms, the only difference is the amino acid
sequence GPWASCPA (position: aa 33-40) missing from isoform B.
The OTX2 protein contains multiple functional domains (Fig. 9). DNA binding is mediated
through the homeodomain (HD), which is responsible for binding to DNA sites related to
the 5´-TAATCC/T-3´consensus sequence. Although the OTX2 is proposed to bind DNA as
a monomer (Chatelain et al. 2006), the formation of homodimers is possible through the
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HD and C-terminal regions (Nakano et al. 2000). In addition, the HD is postulated to
undergo interactions with other transcription factors such as MITF (Table 5) (Martinez-
Morales et al. 2003). The HD also harbours a nuclear localization signal (NLS) between
amino acids 35 to 97 (Chatelain et al. 2006). The functions of the conserved glutamine-rich
domain (Q domain) and the SIWSPA motif at the C-terminus are not clear but there is
some evidence that  they are  involved in  protein-protein  interactions  (Larder  and Mellon
2009). The SIWSPA motif is a conserved region found in several HD proteins such as
engrailed-2 that is required for guidance of RGC axons (Heimbucher et al. 2007, Larder
and Mellon 2009). In contrast to the RPE-specific genes where the OTX2 HD appears to
participate in the transactivation process, in the photoreceptor-specific IRBP promoter, the
OTX2 HD displays only DNA binding activity (Chatelain et al. 2006). Transactivation of
the IRBP gene is thought to be mediated via the OTX2 N-terminal (aa1-35) and C-terminal
regions [aa263-275, aa281-293; so-called duplicated activation domain
(DCLDYKDQTA/SSWK)].
Figure 9. Structure of OTX2 and its known functional domains. The highly conserved
homeodomain  (HD,  amino  acids  35-90)  contains  a  DNA  binding  domain  (DBD).  In  addition,
subdomains for extracellular secretion (Sec), internalization (Int), and nuclear localization
signal (NLS) reside within the HD although their specific locations are not known. The putative
eIF4E binding motif (amino acids 10-15; YXXXXL) for modulation of protein translation is
present in the N-terminal  domain (ND) of  OTX2. The glutamine rich region (Q, 103-109 aa),
the  SIWSPA  motif  (158-166  aa)  for  protein-protein  interactions  and  the  duplicated  domain
(2xAD; amino acids 263-275/281-293) for transactivation are located in the C-terminal domain
(CD). Adapted from Nedelec et al. 2004, Chatelain et al. 2006, Sugiyama et al. 2008.
There  is  recent  data  suggesting  that  the  role  of  OTX2  is  much  more  diverse,  with  novel
subdomains for extracellular transport and interactions with protein synthesis (Nedelec et
al. 2004, Brunet et al. 2005, Joliot and Prochiantz 2008). Secretion and internalization of
OTX2 into  neighboring cells  have been verified in  animal  models  where  OTX2 has  been
transferred via the visual pathway from the retina to the visual cortex to control the
cellular plasticity (Sugiyama et al. 2008 and 2009). In cytoplasm, OTX2 is proposed to
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modulate protein synthesis by interacting with the eukaryotic translation initiation factor
4E (eIF4E) (Nedelec et al. 2004, Brunet et al. 2005). The consensus motif (YXXXXL) for
eIF4E binding is found in the N-terminus of several HD proteins (Fig. 9) although there is
no published data which would clarify the function of this specific motif in OTX2 (Nedelec
et al. 2004, Brunet et al. 2005).
Table 5. Proposed target genes and protein-protein interaction partners of the OTX2 in the eye
and brain.
Gene Site of expression  Protein function  Reference
CRX  retinal/pineal gland  transcription factor Nishida et al. 2003, Hennig et al. 2008
Rax   retinal transcription factor Danno et al. 2008
HIOMT   pineal gland melatonin synthesis Dinet et al. 2006
  photoreceptors
IRBP  neural retina retinoid bindin Fong and Fong 1999,
Bobola et al.1999, Dateki et al. 2008
BEST-1  RPE chloride channel Esumi et al. 2009
TYR    RPE/melanocytes melanogenesis Martinez-Morales et al. 2003
TRP-1   RPE/melanocytes melanogenesis Martinez-Morales et al. 2003
DCT    RPE/melanocytes melanogenesis Takeda et al. 2002
tenascin-C retina promotes growth of Gherzi et al. 1997, Briata et al.1999
retinal axons Siddiqui et al 2008
HESX1  pituitary gland transcription factor Diaczok et al. 2008, Dateki et al. 2008
POU1F1  pituitary gland transcription factor Diaczok et al. 2008, Dateki et al. 2008
GnRH  hypothalamus tropic hormone Kelley et al. 2000, Kim et al. 2007
Larder et al. 2009
MITF   RPE /melanocytes transcription factor Martinez-Morales et al. 2003
Masuda and Esumi 2010
Sox2   retinal/pituitary gland transcription factor Danno et al. 2008
SOX9  RPE transcription factor Masuda and Esumi 2010
FOXA2  brain/DA neurons transcription factor Nakano et al. 2000
LIM1  retina/brain transcription factor Nakano et al. 2000
TLE4  brain co-repressor Heimbucher et al. 2007
CRX  =  cone-rod  homeobox  protein,  DCT  =  dopachrome  tautomerase,  FOXA2  (HNF3)  =  forkhead  box  A2,
GnRH  =  gonadotropin-releasing  hormone,  GPR143  (OA1)  =  G-protein-coupled  receptor  143,  HESX1  =  HESX
homeobox  1,  HIOMT  =  hydroxyindole-O-methyltransferase,  IRBP  =  interstitial  retinal  binding  protein,  DA  =
dopaminergic, MITF = microphthalmia-associated transcription factor, POU1F1 = POU class 1 homeobox 1, Rax
=  retina  and  anterior  neural  fold  homeobox  ,  Sox2  =  SRY-box  2,  SOX9  =  SRY-box  9,  TLE4  (GRG4)  =
transducin-like enchancer of split 4, TYR = tyrosinase, TYRP1 = tyrosinase-related protein 1.
The role of OTX2 in the developmental network of the eye and brain has been relatively
extensively studied, but the regulators controlling OTX2 expression remain somewhat
elusive. The OTX2 promoter is known to be up-regulated by homeobox proteins HOXB1-3
as well as by COUP transcription factors (NR2F1/2) (Guazzi et al. 1998, Fossat et al. 2005,
Westenskow et al. 2009, Tang et al. 2010). In addition, animal models indicate that in the
RPE, both MITF and OTX2 are up-regulated by the Wnt/-catenin pathway (Fujimura et
al. 2009, Westenskow et al. 2009).
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2.4 OVERVIEW OF MAIN EXPERIMENTAL MODELS OF THE RETINA
In vivo animal models are valuable tools in eye research for functional studies and for tests
of potential therapeutic applications. Animal models are useful in assessing biological
phenomena in vivo and they enable observation of phenotypic changes after genomic
alterations. In addition, numerous animal models based on spontaneous mutations and
genetically modified mouse/rat strains are utilized in eye research to study candidate
genes and mechanisms at the molecular level (Paskowitz et al. 2006). For instance, many
studies on AMD utilize models such as Royal College of Surgeons (RCS) rats which have a
defect in phagocytosis of POS, and subsequently suffer a progressive retinal degeneration
(Strauss et al. 1998, Zhang and Bok 1998, Strick et al. 2009). Furthermore, models for rare
retinal disorders such as LCA (den Hollander et al. 2008), RP (Rivas and Vecino 2009) and
albinism (Lavado and Montoliu 2006, Beermann et al. 2004) are commonly used. However,
the maintenance of rodents and larger animals can be very expensive. Importantly, certain
biological processes may vary between strains and animal species and differ substantially
from those encountered in the human (Williams et al. 2004).
Retinal in vitro models of primary cultures are widely used in eye research and
spontaneously arisen or genetically modified cell lines modelling various retinal cells are
commonly available (Seigel 1999). Primary cultures of the retinal cells may retain their
typical cell morphologies and express cellular markers but the maintenance of these cells
can be difficult. The function of genes/proteins at the molecular level, complex biological
systems and role of extracellular substances can be studied in these models although some
cell-specific functions are often lost in immortalised retinal cell lines (Alge et al. 2006,
Strunnikova et al. 2010). For example, retinoblastoma (Rb) cell lines Y79 (Reid et al. 1974)
and WERI-Rb1 (McFall et al. 1977) are widely used as photoreceptor models (Glubrecht et
al. 2009) although the photoreceptor-specific markers such as rhodopsin are expressed at
very low levels (Peng and Cheng 2007).  These Rb cells grow naturally in suspension but
when attached onto culture support, their cell cycle is usually arrested and they exhibit a
tendency to differentiate either towards photoreceptors or RPE-type cells depending on
the culture conditions (Chader 1987). For instance, in adherent cultures, when Y79 cells
were cultured in serum-free medium, they differentiated into neuronal-like cells with long
neuronal processes. In the presence of laminin and butyrate, the cells differentiated into
flat epithelial-like cells from which about 20% of the cells were capable of undertaking
melanosome formation.
One of the most widely used RPE model is the ARPE19 cell line where RPE-specific gene
expression, cell polarization, phagocytosis and morphology are preserved to some extent
(Dunn et al. 1996, Biesemeier et al. 2010, Strunnikova et al. 2010) although the most
outstanding and complex marker, melanization, is lost. The lack of significant TYR activity
and the poor capability for melanization is a common feature in both cultured and
primary RPE cells (Smith-Thomas et al. 1996, Abul-Hassan et al. 2000, Rambhatla et al.
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2002, Kanuga et al. 2002, Lu et al. 2007). In another human RPE cell line, D407 (Davis et al.
1995) and hTERT-RPE (Rambhatla et al. 2002, Alge et al. 2006) the RPE-specific features
described above are less evident as in ARPE-19 cells. Specific markers for RPE maturation
such as epithelioid morphology with elevated transepithelial resistance (Mannermaa et al.
2010), apical microvilli and melanosomes as well as genetic markers of retinoid
metabolism (CRALBP, RPE65), melanogenesis (TYR, TYRP-1), cytokeratins (CK8 and18)
and  bestrophin-1  are  usually  determined  from  cell  cultures  derived  from  RPE (Table 6)
(Burke 2008). It is commonly observed that although the mRNAs of these markers are
readily detected, their proteins are not present or their expression requires special culture
conditions or culture support systems (Burke 2008, Mannermaa et al. 2010). In general, it
seems that all these cell-specific features which are characteristic for the RPE are best
preserved in primary cultures of fetal RPE (Maminishkis et al. 2006, Burke 2008). For
instance, primary cultures of the adult RPE lose their pigmentation gradually after several
cell divisions (Kanuga et al. 2002, Burke 2008) whereas the primary RPE cells from fetal
origins display some tendency towards melanin formation.
Table 6. Characteristics of the most common cultured human RPE cell models.
RPE model: ARPE-19 D407 hfRPE
apical microvilli YESa incomplete YESf
TEER (cm2) 50-100a NA >100f
phagocytic activity YESh YESd YESh
melanin synthesis - c - d YESf,h
TYR mRNAb NA mRNAh
RPE65 mRNAa,b NA proteinf,i
CRALBP proteina proteind proteinf
bestrophin-1 mRNAb, e mRNAe proteinf,i
PEDF - g NA proteinf
cytokeratins NA proteind proteinf
ezrin NA NA proteinf
occluding NA NA proteinf
ZO-1 NA NA proteinf
MITF NA NA mRNAh
OTX2 NA NA mRNAh
hfRPE = human fetal primary RPE cells, TER = transepithelial electric resistance, NA = not analyzed.
a Dunn et al. 1996, b Mannermaa et al. 2010, c Biesemeier et al. 2010, d Davis et al. 1995, e Marmorstein
et al. 2000, f Maminishkis et al. 2006, g Tong et al. 2006, h Buchholz et  al.  2009, i Strunnikova et al.
2010.
2.5 GENE TRANSFER INTO RETINAL CELLS
Viral gene and siRNA delivery methods are efficient and widely used for a variety of
applications ranging from in vitro studies  to  retinal  gene  therapy  trials  (Kumar-Singh
2008), although there are safety concerns such as immune reactions and scale limitations in
production (Smaglik 1999, Somia and Verma 2000, Tros de Ilarduya et al. 2010). For
RPE-
specific
markers
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instance, after successful treatment of Briard dogs that were suffering from an inherited
blindness resembling LCA (Acland et al. 2001, Chung and Traboulsi 2009, MacLaren 2009),
the first clinical human gene therapy trials were initiated (Chung and Traboulsi 2009).
Non-viral gene delivery (transfection) by using chemical DNA carriers typically display
poor transfection efficiency and short-term transgene expression as compared to viral
methods (Chaum et al. 1999, Somia and Verma 2000). In particular, gene delivery into
retinal cells is difficult and therefore special strategies have been developed (Chaum et al.
1999, Andrieu-Soler et al. 2006). Retinal cells such as RPE and photoreceptors are usually
non-dividing, with the cell cycle arrested at the post-mitotic phase which hinders gene
delivery (Urtti et al. 2000).
The cellular barriers that limit gene delivery and mechanisms of cellular uptake have been
debated (Kircheis et al. 2001, Thomas and Klibanov 2003, Cohen et al. 2009). There are
many potential barriers such as extracellular proteins, cell surface, trapping into
intracellular proteins or into organelles such as lysosomes as well as nuclear membrane
which can limit gene delivery (Ruponen et al. 1999 and 2003, Männistö et al. 2007).
Moreover the limiting role of the nucleus itself may be underestimated, as there is
evidence that DNA may reach the nucleus rather easily but once there is poorly
transcribed in a carrier-dependent fashion (Cohen et al. 2009).
2.5.1 Gene delivery systems
Non-viral  gene  delivery  with  synthetic  DNA  carriers  is  widely  used  in in vitro studies
(Ruponen et al. 1999, Liao and Yau 2007). Typical synthetic carriers are liposomes or
polymers with a cationic feature that allow electrostatic interactions with the negatively
charged DNA and also with the cell surface (Kircheis et al. 2001). Cationic liposomes with
polar head groups form condensed DNA lipoplexes which interact with cell membranes
and endosomal vesicles by lipid fusion (Mönkkönen and Urtti 1998). Liposomes such as
DOTAP, DOTMA and DOGS and their mixtures with other membrane-destabilizing lipids
such as cholesterol or DOPE are commonly used (Ruponen et al. 1999, Wasungu and
Hoekstra 2006). Cationic polymers that form tightly packed DNA polyplexes are thought
to be taken up by endocytosis and probably released from endosomes by osmotic swelling
and vesicle bursting which is typical for branched polyethylenimines (PEIs) (Boussif et al.
1995, Kircheis et al. 2001, Thomas and Klibanov 2002, Akinc et al. 2005). PEIs with
different molecular weights (25-800 kDa), or with linear or branched structures and other
polymers such as poly-L-lysine (PLL, 20-200 kDa), biodegradable chitosans and
dendrimers of different generations have been systematically studied (Ruponen et al. 1999,
Park et al. 2006, Brissault et al. 2006, Rudzinski and Aminabhavi 2010). Moreover,
polyplexes  can  be  conjugated  with  polyethylene  glycol  (PEG),  signal  peptides  and
antibodies to enhance delivery, stability or targeting of the DNA cargo (Thomas and
Klibanov 2002 and 2003, Ahn et al. 2002, Park et al. 2006).
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2.5.2 Reverse transfection
Non-viral gene delivery can be performed either conventionally (Fig. 10A) by mixing
DNA and the carrier, followed by instantaneous addition of the DNA/carrier complexes
onto the adherent cells (Mönkkönen and Urtti 1998) or by “reverse transfection” (Ziauddin
and Sabatini 2001) where complexes have been prepared on solid supports or within
hydrogels.  This  can  provide  prolonged  stability  for  the  complexes  and  promote  their
controlled release after their introduction of cells (Fig. 10B).
In reverse transfection, DNA/carrier complexes are typically attached onto the solid
surface of culture plates or glass slides (Ziauddin and Sabatini 2001, Wu et al. 2002, Segura
et al. 2005, Erfle et al. 2008, Lei et al. 2009). Although the carrier molecules are similar to
those used in conventional transfection, gene delivery from solid surfaces or hydrogels has
several advantages. Support-bound DNA/carrier complexes enable sustained and
controlled release of DNA (Pannier and Shea 2004). In addition, the surface bound
complexes provide a positive net charge to attract the cells, which is advantageous
especially when cells in suspension are beeing used (Kato et al. 2004). Transfection
efficiencies are higher than with conventional transfection, especially so with primary
Figure 10. Schematic illustration of the conventional (A) and reverse transfection (B) methods.
A) In conventional transfection, fresh DNA/carrier complexes are prepared and added into the
cell culture medium. B) In reverse transfection, DNA/carrier complexes are immobilized on a
solid surface (reviewed by Sturzl et al. 2008). At the moment of transfection, cells are seeded
and DNA/carrier  complexes promote cell  adhesion and the uptake of  the complexes.  In both
cases, carrier molecules condense DNA into tightly packed, positively charged DNA/carrier
complexes. Complexes attracted by the negative cell surface are brought into the intracellular
space via endocytosis. Then the complexes are released from endosomes and delivered into
cell nucleus for transgene expression.
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cultures (Yoshikawa et al. 2004) probably due to the close contact between the cells and
complexes. It is noteworthy that in in vivo applications, reverse transfection can provide
localized gene delivery that  may minimize  adverse  effects  at  the  systemic  level  (Pannier
and Shea 2004).
DNA/carrier complex stabilization and storage – DNA and DNA/carrier complexes are
prone to degradation or display decreased bioactivity when stored in fluids
(Anchordoquy  et  al.  2001).  The  DNA/carrier  complexes  suspended  in  a  liquid  will  soon
aggregate and then transfection activity declines (Anchordoquy et al. 2001). One
advantage of reverse transfection is the improved stability of the dried DNA/carrier
complexes and reconstituted bioactivity upon rehydration (Silva et al. 2004, Fujita et al.
2007). Moreover, the stability of dried DNA/complexes may allow the production, storage
and reproducibility of DNA/carrier complexes on a large scale (Höbel et al. 2008). In
freeze-drying, lyoprotectants such as sucrose and trehalose have proved to be good
stabilizers for the biological activity of proteins and DNA (Talsma et al. 1997,
Anchordoquy et al. 2001). It has been postulated that during freeze-drying, water is
replaced by disaccharides that form an amorphous glass phase which stabilizes the
structure of DNA/carrier complexes. When freeze-dried biomolecules are prepared and
stored under proper conditions, long-term stability from months to years can be achieved
(Anchordoquy et al. 2001, Armstrong and Anchordoquy 2004, Andersen et al. 2008).
Applications – Development of the reverse transfection method may lead to advanced
applications in biosciences where cDNA expression and gene knockdown by using small
interfering RNAs (siRNA) can be performed in a high density arrays (Mousses et al. 2003,
Wheeler et al. 2005, Fujita et al. 2007, Andersen et al. 2007, Erfle et al. 2008, Stürzl et al.
2008). Moreover, screening of gene promoters and drug targets can be substantially
streamlined by incorporating this method (Cheng et al. 2010, Bailey et al. 2002, Mishina et
al. 2004). Furthermore, reverse transfection can be combined with high-content analysis
wherein phenotypic analysis of cells or expression of a large assortment of fluorescent
proteins can be followed by using automated microscopy (Mousses et al. 2003, Erfle et al.
2004, Neumann et al. 2006, Erfle et al. 2007, Conrad et al. 2004, Reymann et al. 2009,
Neumann et al. 2010).
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3 Aims of the Study
The regulatory mechanisms and function of the retinal genes in humans is usually
predicted from rodent models. These animals have nocturnal behaviour and dichromatic
colour vision which lacks the cone-rich central retina (macula) typical for cell organization
in the human retina. These fundamental differences between the human and rodents may
lead to false interpretations and disinformation regarding human retinal functions and
diseases. Therefore, this work was aimed to characterize the regulation of certain retina-
specific human gene promoters and to develop better non-viral gene delivery systems for
the established human retinal cell models. Especially, regulation of human tyrosinase in
RPE  and  the  role  in  this  process  of  two  transcription  factors,  MITF  and  OTX2,  were
studied in detail.
Specific aims of the study were:
I. To clone certain photoreceptor-specific human gene promoters (rhodopsin,
rod arrestin, rod transducin-,  rod  PDE,  IRBP  and  cone  blue  opsin) and
study their activity in established human photoreceptor cell models.
II. To develop an efficient non-viral gene delivery method for post-mitotic
retinal cells.
III. To investigate the transcription factor –driven regulation of the human
tyrosinase in the human RPE cells.
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4 Experimental Procedures
Detailed descriptions of the experimental procedures are shown in the original
publications I-III.
4.1 CELL CULTURE (I-III)
WERI-Rb1 (ATCC HTB-169) retinoblastoma cells were maintained as suspension cultures
in RPMI 1640 medium supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml
penicillin  and  100  µg/ml  streptomycin  antibiotics.  For  RNA  isolation,  microscopy  and
transfection analyses, the cells were seeded onto PLL-coated and PLL/laminin-coated 24-
well Costar plates or Transwell membranes and cultured for 3 or 7 days at + 37oC and 5%
CO2. The human retinal pigment epithelium cell lines ARPE19 and D407 were maintained
in DMEM/F-12/10% FBS/antibiotics and DMEM/5% FBS/antibiotics, respectively. Human
kidney epithelial HEK-293 (ATCC CRL-1573) and monkey kidney fibroblast CV-1 (ATCC
CLL-70) cells were maintained in DMEM/10% FBS/antibiotics with and without 2 mM L-
glutamine, respectively. Cells were kept at + 37oC and 5% CO2. Primary cultures of bovine
and fetal human RPE cells (III) were maintained in DMEM/F-12/10% FBS/antibiotics.
4.2 ELECTRON AND CONFOCAL MICROSCOPY
For electron microscopy, WERI-Rb1 cells (65 000 cells/cm2) were cultured on PLL/laminin-
coated Transwell polycarbonate membranes (Costar) for 7 days. Sample preparation and
electron microscopy (ESEM, Joel JEM-1200EX, Japan) were performed as a service activity
in the Department of Electron Microscopy, University of Kuopio. For confocal microscopy,
WERI-Rb1 cells (60 000 cells/cm2) were culture on Lab-Tek®II 8-coverglass chambers
(Nalge, Nunc, Naperville, IL, USA) for 4 to 7 days. Fixation of the cells samples was
performed with 4% paraformaldehyde (30 min), 0.25% Triton X-100 (15 min), 2% goat
serum with RNase A (1 mg/ml) for 60 min at room temperature. Primary antibody (1:500)
SMI 31(Sternberger Monoclonals Inc., Baltimore, MA, USA) specific for neurofilament H
was detected with fluorescein-conjugated goat anti-mouse IgG (Calbiochem, Darmstad,
Germany).  Cell  nuclei  were  counter-stained  with  propidium  iodide.  The  images  were
collected using a UltraWIEV confocal imaging system (Perkin Elmer Life Sciences, UK)
connected to a Nikon Eclipse TE300 microscope (Nikon, Japan).
4.3 GENE DELIVERY STUDIES (I-III)
The conditions for DNA complex formation were optimized in preliminary experiments
for each cell line and DNA carrier as described in the original publications I and II.
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4.3.1 Conventional transfection (I, II)
DNA carriers PEI25, PEI750, DOTAP and the calcium phosphate method (Chen and
Okayama 1987) were used according to described protocols (I, II) at optimal DNA/carrier
ratios. Cells were seeded 24 hours before transfection. For conventional transfection,
WERI-Rb1 cells were seeded onto PLL/laminin-coated plates. Before transfection, the
medium was changed with serum-free medium and DNA/carrier complexes were added.
After 4–5 h, the transfection medium was replaced with fresh culture medium containing
serum. After two days, transfected cells were collected for analysis.
4.3.2 Reverse transfection (II, III)
DNA carriers PEI25 and PEI750 were prepared at optimal DNA/carrier ratios. In reverse
transfection, DNA/carrier complexes were added into empty 48 well plates. After addition
of the complexes, the plates were snap-frozen on dry ice and freeze-dried overnight on
pre-cooled metal coolers (-80oC) (II, Fig. 1). After freeze-drying, the plates were stored (up
to 6 months) at 4oC in a desiccator until used for transfection. After storage, cells were
seeded on these plates and transfection was carried out in the presence of 10% serum
without any treatments or medium changes before analysis.
4.3.3 Cell viability tests (I, II)
For optimization of gene delivery systems, toxicity of the DNA carriers was monitored by
using the MTT assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(Mosmann 1983).
4.4 RNA ISOLATION AND cDNA SYNTHESIS (I, III)
Total RNA was isolated from cells on various plate formats or flasks by using TRI-Reagent
(Sigma).  Isolated  RNA  was  treated  with  DNase  (DNA-Free  Kit,  Ambion,  Austin,  TX)  to
eliminate genomic DNA contamination. RNA concentrations were determined with the
RiboGreen quantitation reagent (Molecular Probes, Eugene, OR).  Complementary DNAs
were synthesized by using 2 µg heat-denatured RNA, random hexamer primers
(Pharmacia) and M-MuLV reverse transcriptase (Fermentas) (I, III). RNA was isolated and
quantified by using the TaqMan Gene Expression Cells-to-CT Kit (Applied Biosystems) in
48-well plates (III).
4.5 PRIMER DESIGN AND QUANTITATIVE POLYMERASE CHAIN
   REACTION (qRT-PCR)
Intron-spanning primers for quantitation of rod arrestin, cone blue opsin, IRBP, MITF-D,
MITF-H,  rod  PDE, rhodopsin, rod transducin- and  TYR  mRNA  were  designed  by
using the OLIGO (Molecular Biology Insights, Inc., Cascade, CO) and BLAST programs (I,
III). The TaqMan primer/probe set for the human -actin mRNA was designed by using
Primer Express (Applied Biosystems, Foster City, CA) (III). TaqMan primer/probe sets for
MITF-A (Hs01115553_m1), MITF-M (Hs00165156_m1) and OTX2 (Hs00222238_m1) were
ordered  from  Applied  Biosystems.  The  detection  of  rod  arrestin,  cone  blue  opsin,  IRBP,
rod PDE, rhodopsin and rod transducin-mRNA was performed by using conventional
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semiquantitative PCR (I).  Quantitations  of  TYR,  MITF-D  and  MITF-H  mRNA  were
performed with the SYBR Green PCR Master Mix (Applied Biosystems) with final primer
concentrations of 100 nM (III). For SYBR Green PCR and TaqMan PCR (TaqMan Universal
PCR Master Mix, Applied Biosystems), with 40 ng of cDNA being used in the final 15 µl
reaction volume. All quantitative PCRs were performed by in the ABI Prism 7500
instrument (Applied Biosystems) and all collected data were normalized to expression of
the endogenous -actin mRNA or to total cellular RNA quantified with the RiboGreen
assay (III). The specific amplification of target cDNA with SYBR Green assays was verified
by performing a direct melting curve analysis.  Data analysis was performed by using Q-
Gene program (Muller et al. 2002).
4.6 CLONING OF THE HUMAN RETINA-SPECIFIC PROMOTERS AND
  SITE-DIRECTED MUTAGENESIS (I, III)
For cloning of the human gene promoters (rod  arrestin,  cone  blue  opsin,  IRBP,  rod  PDE,
rhodopsin, rod transducin- and TYR) and mutagenesis of specific DNA binding elements,
sequence-specific  primers  were  designed  by  using  the  OLIGO  primer  analysis  software.
The BLAST algorithm and the global multiple sequence alignment tool (ClustalW) were
used to compare sequences and to facilitate the design of primer pairs covering conserved
promoter regions. Photoreceptor- and RPE-specific promoter fragments were amplified by
high-fidelity  PCR  from  human  genomic  DNA,  and  the  fragments  were  inserted  into  the
pGL3-Basic (Promega) luciferase reporter plasmid. The cloned promoter constructs and
some unpublished plasmids are shown in Figures 11 and 12. Details of the cloning are
described in original publications I and III. The established MITF and the putative OTX2
binding sites in the human tyrosinase promoter were mutated by using QuickChange II XL
Site-Directed Mutagenesis Kit according to the manufacturer’s instructions (Stratagene, La
Jolla,  CA)  with  designed  mutagenic  primers  (III, Appendix 1). The mutated constructs
were identified by diagnostic restriction enzyme digestions and verified by dideoxy
sequencing.
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Figure 11. Photoreceptor-specific  gene  promoters  cloned  into  the  firefly  luciferase  (LUC)
reporter vector. Cloned promoter fragments of the human rod arrestin, cone blue opsin, IRBP,
rod PDE, rhodopsin and rod transducin-genes are shown relative to transcription from the
start site (+1). The photoreceptor-specific genes are regulated by several homeodomain
proteins such as CRX, OTX2, RAX and QRX (Furukawa et al. 1997, Chen et al. 1997, Wang et
al.  2004)  and  the  leucine  zipper  protein  NRL  (Kawamura  et  al.  2005,  Cheng  et  al.  2006,
Hennig et al. 2008). Proposed cis-acting elements (BAT-1, bts, PCE-1 and PCE-4) may interact
with different   homeodomain transcription factors depending on the target gene and cell type.
BAT-1 = bovine A/T-rich sequence 1 (Desjardin and Hauswirth 1996), bts = bicoid binding site
for  CRX or OTX2, CRX = cone-rod homeobox, GC = specificity protein-4 (Sp-4) binding site,
NRE  =  NRL  binding  element, NRL  =  neural  retina  leucine  zipper,  OTX2  =  orthodenticle
homeobox  2,  PCE-1  (Ret-1)  =  photoreceptor  conserved  element-1,  PCE-4  (Ret-4)  =
photoreceptor conserved element-4, QRX (RAX2) = retina and anterior neural fold homeobox
2, RAX = retina and anterior neural fold homeobox, RER = Rhodopsin enhancer region (Nie et
al. 1996).
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Figure 12. Tyrosinase gene promoter fragments cloned into the firefly luciferase (LUC) reporter
vector. The cloned promoter fragments are shown relative to the transcription start site (+1).
Putative OTX2 binding sites (1, 2 and 3), and MITF binding sites [M, E boxes and tyrosinase
distal element (TDE)] are shown in the uppermost construct. Mutated (X) or deleted regions of
each promoter are indicated. The functional SNP rs4547091 in position -223C (TAATCT 
TAAcCT) at putative OTX2 site 3 is indicated by boxed SNP.
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4.7 PROMOTER ANALYSIS (I, III)
To assess the functionality of the cloned promoters, constructed luciferase reporters were
transfected into cells by using conventional (I) or reverse transfection (III). The beta-
galactosidase expression vector pCMV was used for normalization. In order to assess
putative regulatory elements in cloned promoters, co-transfections with CMV-driven
OTX2 or MITF expression vectors were performed. An empty pCR3 expression vector was
used to adjust for total DNA concentrations (III). Reverse transfection assays were
performed on 48-well plates as described (II, III).
4.8 YEAST TWO-HYBRID ASSAYS (III)
In order to study potential protein-protein interactions between the OTX2 and MITF
transcription factors, constructs coding for full-length proteins or their subdomains
(Figure 14) were created by utilizing the pGBKT7 and pGADT7 plasmids within the yeast
two-hybrid (Y2H) system (Matchmaker GAL4 System3, BD Clontech Laboratories Inc.,
Mountain View, CA). In the Y2H system, interacting factors were expressed within the
yeast  cells  as  a  separate  proteins  fused  with  the  DNA-binding  domain  (DBD)  or  the
activation domain (AD)(Gietz et al. 1997). The occurrence of a physical interaction
between the factors, and by implication the close proximity of DBD and AD, was observed
by immediate activation of the reporter gene. Details of the cloning of OTX2 and MITF
fusion constructs are described in publication III.
4.9 ELECTROPHORETIC MOBILITY SHIFT ASSAYS (III)
The electrophoretic mobility shift assay (EMSA) and supershift experiments with specific
antibodies were used to study the novel OTX2 and known MITF binding elements in the
human tyrosinase promoter. For EMSA, oligonucleotide probes containing the wild-type
and mutated binding sites for MITF and OTX2 were designed (III, Appendix 2). Double-
stranded probes were labeled with [-32P]dCTP (GE Healthcare) by using the Klenow
fragment (MBI Fermentas) and purified with Quick Spin columns (GE Healthcare). The
preparation of nuclear extracts from APRE-19 cells cultured for 14 days and the optimized
conditions for the EMSA reactions are described in the Supplementary Material of original
publication III.
4.10 GENE SILENCING EXPERIMENTS (III)
The purpose of this experiment was to demonstrate the effect of OTX2 and MITF
knockdown  on  TYR  expression.  Silencing  of  OTX2  and  MITF  mRNA  expression  in
ARPE19 cells was performed by utilizing RNAi techniques with OTX2- and MITF-specific
Silencer® Select siRNAs (s9933, s8790; Ambion, Austin, TX) in a final concentration of 25
nM. Shortly, 24 hours after plating on 48-well plates (0.75x105 cells per well) ARPE19 cells
were transfected by using Mirus TransIT-TKO transfection reagent (Mirus, Madison, WI)
according to the manufacturer’s instructions. RNA isolation, DNase treatment and cDNA
synthesis was performed 48 hours after transfection by using the TaqMan Gene
Expression  Cells-to-CT  Kit  (Applied  Biosystems,  Foster  city,  CA).  Silencer®  Select
Negative Control #1 siRNA (Ambion, Austin, TX) was used to monitor the effects of
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siRNA delivery in each experiment. The endogenous TYR, OTX2 and MITF-A mRNA
levels were quantified and normalized to -actin mRNA expression as described in
sections 4.3-4.4.
5 Results and Discussion
5.1 GENE DELIVERY INTO RETINAL CELLS (I, II)
On  adherent  cultures,  WERI-Rb1  cells  are  non-dividing  (McFall  et  al.  1977)  and  thus
provide a realistic model for evaluating novel gene delivery systems for post-mitotic
retinal  cells.  Generally,  gene  delivery  into  non-dividing  cells  is  very  inefficient  when
compared to actively dividing cells (Ohki et al. 2001) and relatively large amounts of cells
and DNA are usually required.
Conventional transfection (I, II) – In order to test the activity of cloned retina-specific
promoters, several different gene delivery systems were tested with either the
conventional calcium phosphate precipitation method, cationic lipids and polymers.
Cationic polymers PEI25 and PEI750 displayed the highest activities in WERI-Rb1 cells at
charge ratios ±2 and ±4, respectively. The cationic polymer PEI750 was the most active
carrier in WERI-Rb1 cells, displaying about 50-fold higher activity compared to the
calcium phosphate precipitation method. The activity of PEI25 and DOTAP was about
20% and 5% of the PEI750 -carrier, respectively. However, PEI750 was sensitive to the
presence of serum in the culture medium (Figure 13A). In the presence of 10% serum, the
activity of PEI750-based complexes decreased by about 60% whereas the activity of PEI25
was only slightly decreased (~20%).
Reverse transfection (II, III) – In order to improve and simplify the gene delivery into
WERI-Rb1 cells, a straightforward transfection method “reverse transfection” was
developed. In reverse transfection, the DNA/carrier complexes were freeze-dried on the
solid  culture  plate  surfaces  and  stored  until  the  plates  were  used.  On  the  day  of
transfection,  cells  were  seeded  on  the  plates  which  promoted  both  concurrent  cell
adhesion (Figure 13D) and DNA complex uptake into the cells. In reverse transfection,
PEI25 (±4) displayed the highest activity in WERI-Rb1 cells while the activity of the PEI750
(±6) carrier was about 43% of PEI25. It is noteworthy that the presence of serum decreased
the activity of PEI750 carrier, whereas PEI25 displayed the high activity and serum
insensitivity when compared to conventional transfection (Figure 13A). The presence of
sucrose in freeze-dried DNA/PEI complexes was optimal at 1% but it then decreased the
transfection efficiency at higher concentrations (Figure 13B). Freeze-dried complexes
preserved their biological activity upon long-term storage for 6 months (II) up to more
than one year (unpublished data) when the complexes were kept in a dry environment
(Figure 13C). The good stability of the DNA/PEI complexes is probably related to the
presence of an amorphous “glassy” structure which is formed by the presence of sucrose
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in formulation when freeze-dried (Armstrong and Anchordoquy 2004). In normal ambient
humidity (40-50%), the biological activity is lost, which is probably due to altered complex
conformation. Notably, the reverse transfection method was successful in gene delivery
into primary cultures of the human fetal retinal pigment epithelial cells which were post-
mitotic and generally known to be difficult to transfect (III).
Figure 13. Characteristics of reverse transfection into WERI-Rb1 cells. (A) In the presence of
serum, the transfection efficiency of the PEI750 is dramatically decreased whereas the PEI25 is
insensitive  for  serum.  Conventional  and  reverse  transfection  at  optimal  DNA/PEI25  charge
ratio (CR) are shown. (B) DNA/PEI25 complexes at optimal sucrose concentration provide high
transfection efficiency when freeze-dried. (C) The biological activity of the freeze-dried
complexes is well preserved during the long-term storage. (D) Freeze-dried DNA/carrier
complexes increase the adhesion of WERI-Rb1 cells onto the culture surface (unpublished
data).
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Overall, within the group of different gene delivery systems, PEIs were the most efficient
DNA carriers for post-mitotic retinal cells. PEI750 was exceptionally active in adherent
cultures of WERI-Rb1 cells, evidence that the size of the PEI is critical for gene delivery in
this cell type. Typically, PEIs with higher molecular weights (PEI750-800) display lower
activity in cultured cells and in vivo compared to carriers with low molecular weight such
as PEI25 (De Smedt et al. 2000, Kircheis et al. 2001). The reason for this major difference is
unclear  but  it  might  be  due  to  differences  in  the  cell  surface  composition  or  by  the
mechanisms involved in DNA uptake. In addition, these results indicate that the serum
sensitivity  of  the  DNA/carrier  complexes  may  be  related  to  the  molecular  weight  of  the
cationic polymers, with PEI750 displaying serum sensitivity and decreased transfection
efficiency. Importantly, reverse transfection proved to be a straightforward and
reproducible gene delivery method for retinal cells. In reverse transfection, the plates
could be prepared in advance and stored for long periods while still retaining the
biological activity of the complexes. Interestingly, storage for weeks even tended to
improve  the  transfection  efficiency  of  the  complexes.  It  remains  to  be  seen  if  this
enhancement  is  related  to  slow  structural  changes  in  the  complexes  or  lyoprotectants
present in the formulation. As far as is known, there are no published reports that could
suggest any specific mechanism to account for this phenomenon.
5.2 PHOTORECEPTOR-SPECIFIC GENE EXPRESSION IN WERI-RB1
  PHOTORECEPTOR MODEL AND REGULATION OF THE
  PHOTORECEPTOR-SPECIFIC PROMOTERS (I)
In order to assess the differentiation capability of the WERI-Rb1 cell line, morphological
features and endogenous mRNA expression of the photoreceptor-specific genes rhodopsin,
rod arrestin, rod transducin-, rod PDE, IRBP and cone blue opsin were studied in adherent
cultures. When WERI-Rb1 suspension cells were attached onto PLL/laminin-coated
culture plates or Transwell membranes, cell division was arrested and cells formed
rosette-like clusters (Figure 14A) which are proposed to exhibit the features of primitive
photoreceptor cells (McFall et al. 1977). Moreover, axon-like structures (Figure 14B-D)
were observed in adherent cultures which displayed neurofilament-H (Figure 14B),  a
marker of the neuronal phenotype.
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Figure 14. Adherent  cultures  of  WERI-Rb1  cells  display  some  characteristics  of  the
photoreceptors (unpublished data). (A) Formation  of  rosettes  is  seen  in  WERI-Rb1  cells
cultured on the Transwell membranes (electron microscope image). (B) Growth  on  a  solid
support  induces  axonal  growth  and  expression  of  the  neurofilament-H,  a  marker
(green/arrows) for neuronal cells (confocal image). The cell nucleus is stained by PI and shown
in red. (C, D) Axon-like growth on Transwell membrane (electron microscope image). The tip
of an axon (shown in D) is in the upper right corner of the panel C (arrowheads).
In WERI-Rb1 cells, expression of PDE and IRBP mRNAs was clearly detectable whereas
levels of rhodopsin, arrestin, transducin- and blue opsin mRNAs were below the limit
of detection of this method (I). These photoreceptor-specific mRNAs were not expressed
in the other cell lines studied (ARPE-19, D407, HEK293 and CV-1).
In order to find conserved regulatory regions within the human photoreceptor-specific
promoters, a sequence comparison with the corresponding rodent promoters and retrieval
of possible transcription factor binding sites was performed. The corresponding fragments
of  the  human rhodopsin, arrestin, transducin-, PDE, IRBP and blue opsin promoters
(Figure 11) were cloned upstream of the pGL3-Basic luciferase reporter. Cell lines WERI-
Rb1, ARPE-19, D407, HEK293 and CV-1 were transfected with these reporter constructs
together with the pCMV beta-galactosidase vector for normalization. Only PDE and
IRBP promoters were active in WERI-Rb1 cells, displaying 7-8 -fold higher activity when
compared to the promoterless pGL3-Basic vector. The PDE promoter showed clear
activity also in other cell lines, displaying the highest activity (78-fold relative to control)
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in CV-1 fibroblasts which indicates a clear lack of cell specificity of this promoter. This
result contrasts with the earlier studies (Ogueta et al. 2000, Lerner et al. 2002, Lerner et al.
2006) that claimed that the proximal human PDE promoter (-297 to +53) was capable of
driving photoreceptor specific expression in the transgenic mouse model via the
transcription factors NRL and specificity protein-4 (SP-4) (Figure 11). The NRL binding
element (NRE) and binding elements BAT-1, PCE-1 and Ret-4 specific for retinal
homeobox transcription factors CRX, RAX and QRX (see Table 3) are commonly found in
the regulatory regions of photoreceptor-specific genes (Wang et al. 2004, Kawamura et al.
2005). The proposed binding elements shown in Figure 11 are relatively well conserved in
vertebrates (Furukawa et al. 1997).
In summary, WERI-Rb1 cells possess some photoreceptor-specific features which can be
readily  detected  such  as  expression  of  PDE and IRBP mRNA whereas the other cell-
specific gene markers were below the limit of detection. In addition, cultured
retinoblastoma cells cannot develop the elongated morphology typical for rods and cones
in the neural retina in vivo, although some morphological features of the photoreceptors
were observed such as axon-like structures and rosettes (Wippold II and Perry 2006). The
levels of transcription factors implicated in photoreceptor differentiation such as NRL,
CRX or OTX2 and the functionality of their binding elements (shown in Figure 11) was not
investigated  in  this  work.  Therefore,  more  comprehensive  studies  concerning  the
expression of these transcription factors and their target genes will be required in the
future.
5.3 REGULATION OF THE HUMAN TYROSINASE PROMOTER IN THE RPE
CELLS (III)
Endogenous expression of tyrosinase mRNA in the RPE cells (III) – The human RPE
cells models, ARPE19 cell line (Table 7) and  fetal  primary  RPE  cells  actively  expressed
TYR mRNA. In  ARPE19 cells,  TYR mRNA level  increased over  time (6h to  30  days)  and
was  accompanied  by  an  increase  in  MITF-A,  -D,  -H  and  OTX2  mRNA  levels  which
reached the highest levels after culturing for 14 to 30 days. Over-expression or knockdown
of  OTX2  in  RPE  cells  resulted  in  corresponding  changes  in  TYR  mRNA  expression.  For
instance, in ARPE-19 cells, partial silencing of endogenous MITF or OTX2 expression by
using specific siRNAs decreased TYR mRNA levels by 37% or 44% relative to the non-
specific control siRNA (100%), respectively. Another human RPE cell line, D407, as
anticipated, was devoid of TYR and OTX2 mRNA expression (Table 7). Importantly, TYR
mRNA expression was activated in D407 cells only after forced expression of OTX2
although endogenous MITF-A and -H expression was the highest of the cell lines studied.
This indicates that MITF alone is not sufficient for activation of TYR mRNA expression in
the RPE at high levels but requires a contribution from OTX2.
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  Table 7. Relative expression of TYR, OTX2 and MITF mRNAs in ARPE-19, D407
  and G-361 cell lines cultured for 96h.
Unfortunately, there are no RPE cell lines that display TYR enzyme activity and active
melanogenesis. Likewise, it was not possible to detect TYR protein expression in ARPE19
cells  although  TYR  mRNA  was  clearly  present  which  is  in  line  with  results  from  other
studies (Abul-Hassan et al. 2000, Kanuga et al. 2002, Rambhatla et al. 2002). This suggests
that TYR is immediately down-regulated in isolated cultures. This phenomenon is also
seen in adult primary RPE cells where the melanosomes disappear soon after cell isolation
(Schraermeyer and Heimann 1999, Burke JM 2008, Kanuga et al. 2002).
Regulation of the human tyrosinase promoter in the RPE and the role of transcription
factors  MITF and OTX2 (III)  – The human tyrosinase promoter region up to -2525 bases
relative to the transcription initiation site (+1) and its enhancer region (-9869 to -8741) was
cloned upstream of the pGL3-Basic luciferase reporter. Several deletion fragments (Figure
12) were assessed to identify the regions required for cell-specific expression in the RPE
(ARPE-19, D407) and melanoma (G-361) cells. Co-transfection with MITF-A and OTX2
expression vectors indicated that putative OTX2 binding sites were located within the
region -462 to -152 and that activation of TYR promoter by OTX2 in the RPE cells was
more  robust  than  that  obtained  by  MITF.  The  presence  of  OTX2  sites  was  evidenced  by
sequence analysis that revealed three putative binding sequences for OTX2 binding at
positions -226 to -221 termed OTX2(3), (TAATCT), -354 to -349 OTX2(2) and -361 to -356
OTX2(1), (TAATCTtTAATAC). This region containing the three OTX2 binding sites is less
conserved between species which suggests that there may be differences in the OTX2-
dependent regulation between the mouse (Martinez-Morales et al. 2003) and human
tyrosinase genes.
To  summarize,  in  the  RPE  cells,  both  proximal  MITF  binding  sites  (M-  and  E-box)  were
required  for  TYR  activation  but  the  M-box  seems  to  have  a  more  active  role (Figure 15)
which was opposite to the situation in melanoma cells where trans-activation was more
dependent on the E-box (APPENDIX II). In the RPE cells, OTX2-mediated activation
occurs via direct binding and activation of all three OTX2 sites. The OTX2(3) displayed a
more crucial role for trans-activation (Figure 15).  This  was  also  evident  in  EMSA
experiments: indicating a highly specific nuclear extract protein binding to OTX2 site 3.
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Moreover, when all OTX2 binding sites were abolished, OTX2 still displayed a high
activation capacity when co-transfected with MITF. This synergistic activation was
dependent on the presence of proximal MITF binding sites, indicative of a protein-protein
interaction between MITF and OTX2.
Figure 15. The role of OTX2 in regulation of the human tyrosinase gene. TYR is differentially
regulated in the RPE and melanocytes. This model presents all known MITF (circles) and OTX2
(squares) binding elements within the human tyrosinase promoter fragment -1995 to +74. In
RPE, activation by OTX2 is mainly mediated throughout the OTX2 binding site  3 whereas in
melanocytes,  OTX2 is not expressed and the role of OTX2 sites and any associated factors is
unknown. In the RPE, the predominant MITF-A binds preferentially to the M box while  in
melanocytes, trans-activation by MITF-M is mediated by all three binding elements (TDE, M
and E boxes). In melanocytes, the human tyrosinase promoter is robustly activated throughout
the distal region (-2525 to -1995) and the enhancer (-9869 to -8741)(APPENDIX II).
+ = level of trans-activation.
Importantly, the role of the SNP (rs4547091) identified in the OTX2 site 3 (T-223C) was
assessed. Interestingly, when this SNP was introduced (TAATCT TAAcCT), there was a
dramatic down-regulation of reporter activity to about 26% of maximum. A similar
reduction was observed in the human fetal primary RPE cells. Moreover, EMSA assays
detected a clear decrease in DNA-protein interaction with the probe when the SNP was
present. It is noteworthy that in the transgenic mouse model (Rachlet et al. 2002), if there
was TYR activity less than 35%, this impaired retinal development. This suggests that the
SNP studied may affect TYR levels, and consequently alter the endogenous L-DOPA and
melanin levels in the RPE in vivo. If true, this might also affect retinal development and
function. Alternatively, if the decrease of TYR levels is more subtle, consequences may
emerge during senescence in the retina when the scavenging capacity of melanin may be
compromised.
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MITF-OTX2 protein-protein interactions (III) – The reporter assays suggested that a
fraction of OTX2-dependent activation of TYR took place via MITF sites. The protein-
protein interactions between MITF and OTX2 were analyzed with the yeast two-hybrid
system  (Y2H)  by  using  full-length  and  truncated  forms  of  these  factors (III). A strong
interaction was observed between the OTX2 DNA-binding homeodomain (HD) and the
trans-activation domain (AD) and serine-rich (S) C-terminal of MITF (Figure 16). Full-
length forms of MITF-A and –M displayed comparable activity which proved that N-
terminal regions were not substantially involved in interaction with OTX2. These results
are in line with co-transfection experiments which displayed a similar synergistic
activation with OTX2 by both MITF isoforms. Interestingly, these results reveal that the
MITF  DNA-binding  domain  bHLH  is  not  required  for  the  interaction  with  OTX2,  as
suggested  earlier  by  the  pull-down  experiments  with in vitro expressed proteins
(Martinez-Morales et al. 2003).
Figure 16. Protein-protein interactions occur between the OTX2 and MITF. (A) Full-length
MITF-A and OTX2 and their known domains are shown with the corresponding amino acids.
(B) Interaction between the full-length and deleted domains of OTX2 and MITF were assessed
by  using  a  yeast  two  hybrid  (Y2H)  system. Full-length OTX2 (FL: residues 1297) and
especially its homeodomain (HD: residues 37109) display a strong binding activity (arrows)
with the tested trans-activation domain (AD1-2: residues 118297) and the serine-rich C-
terminus (AD3-S: residues 402520) of MITF-A. Interactions of A-B1b and bHLH-LZ domains
with full-length OTX2 are below the auto-activation level of full-length OTX2 alone (=1, dashed
line). A = MITF-A specific region, B1b = common region in MITF-A, -D and -H isoforms, AD =
activation  domain,  bHLH-LZ  =  basic  helix-loop-helix  leucine  zipper  region,  S  =  serine-rich
region, ND =N-terminal region, HD = homeodomain, CD = C-terminal region.
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In summary, this study shows that the human TYR gene is differentially regulated in the
RPE and melanoma cells (see Figure 15). In melanoma cells, OTX2 is naturally absent, and
when artificially expressed, it cannot activate the TYR promoter without the proximal
MITF binding sites (Supplementary data). In the TYR gene, the three OTX2 binding sites
and MITF M-box within the proximal promoter (-462 to +74) seem to be most important
for TYR activity  in  the  RPE  cells.  Furthermore,  the  identified  OTX2-MITF  protein
interaction and the synergistic activation of the TYR gene indicates that OTX2 may have
an important role in the modulation of other retina-specific genes regulated by MITF
(Esumi et al. 2007, Chiaverini et al. 2008) even though there might not be any specific
OTX2 binding sites  in  those  genes.  In  the  human RPE cells,  robust  activation of TYR by
OTX2 as well as an inhibitory role of the SNP in the OTX2 site 3 was evident. These results
parallel those obtained with knockout mouse models which have indicated that OTX2 is
involved in retinal melanogenesis and development (Nishida et al. 2003, Koike et al. 2007,
Beby et al. 2010). For instance, knockdown mice with a conditional Otx2 mutation showed
a clear connection between Otx2, Tyr and decreased melanogenesis, leading to retinal
degeneration (Beby et al. 2010). This SNP is more common in the European population
where age-related macular degeneration (AMD) is also more prevalent than in black
individuals of African origin (Bressler et al. 2008, Torero Ibad et al. 2011). Although the
correlation between RPE pigmentation and AMD is evident, there are no generally
accepted susceptibility genes so far identified among the group of pigmentation genes.
It has been proposed that the activity of the tyrosinase gene and melanogenesis within the
RPE is restricted at the last stage in the developing eye and ceases soon after birth. The
putative role of OTX2 and genetic variation at its binding site implies some potential for
reduced melanogenesis which may affect retinal development and have functional effects
on the aging RPE in certain individuals. Decreased levels of cellular melanin diminish the
UV  shield  and  the  antioxidant  capacity  and  may  expose  the  RPE  to  harmful  levels  of
oxidative stress which is exceptionally intense in the retina (Winkler et al. 1999, Hu et al.
2008). It is generally thought that aging diseases such as AMD are associated with
oxidative stress, and the inverse correlation with reduced RPE melanin levels in these
patients has been documented in large epidemiological studies (Thompson et al. 2007, Hu
et al. 2008).
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6 Summary and Conclusions
The present study has given insights into the regulation of retina-specific gene expression,
retinal cell models of the RPE and photoreceptors and their suitability for promoter
studies. In addition, the development of gene delivery techniques for the retinal cells was
a key element of this work.
The findings of the present study are summarized as follows:
1. Reverse transfection is a straightforward and reproducible gene delivery method
that enables gene delivery into “hard-to-transfect” cells such as post-mitotic retinal
cells. In this method, DNA/PEI25 complexes appear to promote cell adhesion and
serve as a microenvironment for concurrent complex uptake even in the presence of
serum. It is noteworthy that in reverse transfection, the plates can be prepared in
advance and stored for long periods (12-24 months) without any detrimental effects
on  the  biological  activity  of  the  complexes.  This  is  a  significant  technical  advance
over the conventional transfection technique performed in liquid phase.
2. WERI-Rb1 and Y79 retinoblastoma cells are commonly used cell models for the
human photoreceptors. When these suspension cells are adhered to culture plates,
photoreceptor-specific features such as arrest of cell division, rosette formation and
axonal growth are induced, all of which suggests that differentiation occurs at least
to a certain extent. These cells were capable of expression of rod-specific markers
IRBP and PDE- but  other  markers  such  as  rhodopsin  were  below  the  level  of
detection. The post-mitotic phenotype limits the gene delivery into these cells, but
the DNA carrier PEI25 and the reverse transfection method were powerful enough
to detect the activity of weak gene promoters.
3. In human RPE, OTX2 is an important regulator of tyrosinase, a rate-limiting
enzyme of melanogenesis. OTX2 activates the human tyrosinase gene promoter via
direct  trans-activation  of  three  novel  OTX2  binding  elements  and  via  proximal
MITF binding sites by a physical protein-protein interaction with MITF.
Importantly, the single nucleotide polymorphism (SNP rs4547091, T-223C) at the
most proximal OTX2 binding site 3 is functional and associated with a dramatic
decrease in tyrosinase promoter activity in RPE cells.
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7 Future Directions
Most of the information concerning photoreceptor-specific gene expression has
originatesd from rodent and bovine models. Thus, there is a clear need to study gene
expression in human cell models. In order to achieve this goal, co-transfection experiments
with human promoters and transcription factors can be relatively easily implemented in
practice by using the reverse transfection method developed here.
In the reverse transfection method, freeze-dried DNA/PEI complexes are stable and
preserve  their  biological  activity  remarkably  well  when  stored.  This  facilitates  further
development of this method as well as new applications. In particular, the increased
biological activity of the complexes during long-term storage is a very interesting
phenomenon. Therefore, a thorough understanding of the relationship between physical
properties and biological activity of the stored complexes should be conducted. This might
well enable better control of the complex release and activity. Importantly, this method
makes possible gene delivery in a high-throughput manner since it  can be conducted on
high-density plates or implemented in a microarray format where hundreds or thousands
of  independent  complexes  are  printed  on  a  solid  support  such  as  microscope  slides.
Freeze-drying of printed arrays may be challenging and especially further optimization of
formulations and drying process will be required. It should be noted that printing of
complexes onto slides on the nanoscale accompanied with a co-transfection and detection
of several expressed fluorescent proteins in living cells simultaneously raise the standards
of sample handling and data acquisition capacity. This has, to some extent, been realized
by adopting robotics and automated image analysis.
OTX2 is a versatile protein with multiple functions. The unique intercellular transit
capability of OTX2 (Sugiyama et al 2009, Torero Ibad et al. 2011) and the present results on
its interaction with MITF suggest that novel OTX2-dependent regulatory pathways might
be revealed in the future. It seems likely that, novel gene and cellular targets will emerge.
The existence of this novel activation mechanism in different MITF target genes and cell
types remains to be investigated. Indeed, data concerning the physical characteristics of
OTX2-MITF interaction are still contradictory, requiring clarification in further
biochemical  and  biophysical  studies.  Understanding  of  MITF-OTX2  interactions  and
differential TYR regulation in RPE and melanocytes may also be useful in developing
novel therapies of skin and ocular melanoma in which MITF and pigmentation are known
factors (Yokoyama et al. 2011, Bertolotto et al. 2011).
The genes involved in RPE pigmentation are potential candidates for retinal degeneration,
but  their  role  has  not  been  studied  in  detail.  The  actual  role  of  the  identified  SNP
rs4547091 in retinal degeneration such as AMD will require replication by genetic
association studies in the future. In addition, SNPs in the regulatory regions of other genes
involved in melanogenesis are also potential candidates for involvement in the abnormal
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RPE pigmentation. Based on this hypothesis, genes such as MC1R, GPR143, PMEL17 and
all  members  of  the tyrosinase gene family as well as their regulators MITF, OTX2 and -
catenin are of interest.
Furthermore, AMD and the neurodegenerative Alzheimer and Parkinson´s diseases share
several strikingly similar features. First, age-related changes in these diseases are found in
the  pigmented  cell  regions  (RPE, substantia nigra, locus ceruleus) which become
progressively degenerated (Zarow et al. 2003, Thompson et al. 2007). Second, the
reduction in the levels of RPE melanin and neuromelanin in the dopaminergic neurons has
been well documented in these tissues (Hoogendijk et al. 1995, Reyes et al. 2003, Schwarz
et al. 2011). Third, there is a negative correlation between the extent of the depigmentation
and the elevated levels of free cellular iron in aging diseases (Hahn et al. 2003, Berg 2006,
Salvador et al. 2011). Fourth, in particular, insoluble protein aggregates (lipofuscin, -
synuclein and beta-amyloid) are present in these diseases (Sparrow and Boulton 2005,
Obeso et al. 2010, Yankner et al. 2008). The similarities in these findings suggest that
common regulatory pathways and candidate genes linked to pigmentation might possibly
be shared within this group of aging diseases.
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This thesis focuses on the regulation 
of genes active in the retinal pigment 
epithelium and photoreceptor cells of 
the human eye. The development of a 
novel gene delivery method, reverse 
transfection, for difficult-to-transfect 
retinal cells is also described. Novel 
information on the regulation of 
tyrosinase expression in human RPE 
cells and the role of a functional sin-
gle nucleotide polymorphism (SNP) 
is presented. The potential associa-
tion of RPE depigmentation to retinal 
development, its function and sub-
sequently on diseases such as age-
related macular degeneration (AMD) 
is discussed.
